{"content":"<li class=\"n-box-item date-title\" data-end=\"1571198399\" data-start=\"1571112000\" data-txt=\"Monday, December 23, 2019\">Tuesday, October 15, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3505999\" data-ts=\"1571193335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NS\" target=\"_blank\">NS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505999-toxic-smoke-from-nustar-oil-storage-fire-forces-shelter-in-place\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toxic smoke from NuStar oil storage fire forces shelter-in-place</a></h4><ul><li>NuStar Energy (NYSE:<a href='https://seekingalpha.com/symbol/NS' title='NuStar Energy L.P.'>NS</a>) <font color=\"red\">-2.6%</font> after-hours as an <a href=\"https://www.kqed.org/news/11780224/shelter-in-place-order-issued-for-rodeo-crockett-following-fire-at-nustar-energy-facility\" target=\"_blank\">explosion and fire</a> at a company fuel storage facility in the San Francisco Bay Area led authorities to order ~12K area residents to stay inside with all windows and doors closed.</li><li>Contra Costa County fire protection officials said  the storage tanks were holding a combined 250K gallons of ethanol when they  erupted in flames and one collapsed.</li><li>The fire and toxic smoke forced a shutdown of Interstate 80, one of the busiest highways in the Bay Area, causing massive backups during evening rush hour; the California Highway Patrol says the closure likely will last until at least midnight.</li><li>Some 200 firefighters reportedly are <a href=\"https://www.marketwatch.com/story/fire-at-bay-area-oil-facility-prompts-health-warnings-to-nearby-residents-2019-10-15\" target=\"_blank\">continuing to battle the fire</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505999\" data-linked=\"Toxic smoke from NuStar oil storage fire forces shelter-in-place\" data-tweet=\"$NS - Toxic smoke from NuStar oil storage fire forces shelter-in-place https://seekingalpha.com/news/3505999-toxic-smoke-from-nustar-oil-storage-fire-forces-shelter-in-place?source=tweet\" data-url=\"https://seekingalpha.com/news/3505999-toxic-smoke-from-nustar-oil-storage-fire-forces-shelter-in-place\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505992\" data-ts=\"1571178272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECD\" target=\"_blank\">TECD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505992-apollo-global-offers-5b-bid-for-tech-data-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Global offers $5B bid for Tech Data - Reuters</a></h4><ul><li>Tech Data (NASDAQ:<a href='https://seekingalpha.com/symbol/TECD' title='Tech Data Corporation'>TECD</a>) <font color=\"green\">+14%</font> after-hours following a Reuters report that Apollo Global Management (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, Inc.'>APO</a>) has approached the company with a <a href=\"https://www.nasdaq.com/articles/exclusive-buyout-firm-apollo-global-in-%245-bln-bid-for-tech-data-sources-2019-10-15\" target=\"_blank\">~$130/share cash buyout offer</a>, amounting to ~$5B.</li><li>The move comes as TECD's shares are hovering at all-time highs on investor optimism that demand from small and medium-sized businesses for its offerings will remain strong despite concerns about the U.S. economy.</li><li>Apollo made an unsuccessful bid last year to acquire U.S. electronics distributor Ingram Micro from HNA Group for as much as $7.5B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505992\" data-linked=\"Apollo Global offers $5B bid for Tech Data - Reuters\" data-tweet=\"$TECD $TECD $APO - Apollo Global offers $5B bid for Tech Data - Reuters https://seekingalpha.com/news/3505992-apollo-global-offers-5b-bid-for-tech-data-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3505992-apollo-global-offers-5b-bid-for-tech-data-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505989\" data-ts=\"1571176766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505989-j-b-hunt-misses-q3-earnings-intermodal-revenue-rises-2-volumes-flat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.B. Hunt misses Q3 earnings; intermodal revenue rises 2%, volumes flat</a></h4><ul><li>J.B. Hunt Transport (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>) <font color=\"red\">-1.6%</font> after-hours as <a href=\"https://seekingalpha.com/news/3505909-j-b-hunt-transport-services-eps-misses-0_05-beats-revenue\" target=\"_blank\">Q3 earnings</a> fall short of expectations while revenues rose 7% Y/Y to $2.36B, edging estimates.</li><li>Q3 revenue in the intermodal segment rose 2% Y/Y to $1.24B, <a href=\"https://www.marketwatch.com/story/jb-hunt-q3-profit-misses-wall-street-targets-2019-10-15\" target=\"_blank\">slightly below analyst estimates</a>, reflecting roughly flat volumes Y/Y and a ~2% increase in revenue per load, while segment operating income rose 10% Y/Y to $132.9M, beating analyst consensus $136.5M.</li><li>Dedicated Contract Services revenue rose 28% Y/Y in the quarter to $696M, as productivity (revenue per truck per week) excluding fuel surcharge revenue gained ~11%.</li><li>However, results from the two segments were offset by a 4% drop in load count in Integrated Capacity Solutions and a 5% decline in rates per loaded mile in the Truck segment.</li><li>JBHT did not update the status of a freight revenue dispute with BNSF Railway, its partner in the intermodal business; the matter is in arbitration, and JBHT has taken more than $100M in related contingency charges.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505989\" data-linked=\"J.B. Hunt misses Q3 earnings; intermodal revenue rises 2%, volumes flat\" data-tweet=\"$JBHT - J.B. Hunt misses Q3 earnings; intermodal revenue rises 2%, volumes flat https://seekingalpha.com/news/3505989-j-b-hunt-misses-q3-earnings-intermodal-revenue-rises-2-volumes-flat?source=tweet\" data-url=\"https://seekingalpha.com/news/3505989-j-b-hunt-misses-q3-earnings-intermodal-revenue-rises-2-volumes-flat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505984\" data-ts=\"1571175038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505984-cah-mck-and-snbr-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CAH, MCK and SNBR among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"green\">+7.0%</font>. <a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a> <font color=\"green\">+8.1%</font>. <a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"green\">+7.5%</font>. <a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a> <font color=\"green\">+4.8%. </font><a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color=\"green\">+4.6%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a> <font color=\"red\">-10.9%. </font><a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics N.V.'>PRQR</a> <font color=\"red\">-9.3%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color=\"red\">-2.4%</font>. <a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a> <font color=\"red\">-1.6%. </font></li></ul><div class=\"tiny-share-widget\" data-id=\"3505984\" data-linked=\"CAH, MCK and SNBR among after hour movers\" data-tweet=\"$ABC $CAH $MCK - CAH, MCK and SNBR among after hour movers https://seekingalpha.com/news/3505984-cah-mck-and-snbr-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505984-cah-mck-and-snbr-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505982\" data-ts=\"1571174846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505982-united-airlines-flies-after-raising-full-year-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Airlines flies after raising full-year earnings guidance</a></h4><ul><li>United Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Airlines Holdings, Inc.'>UAL</a>) <font color=\"green\">+1.5%</font> after-hours as it tops <a href=\"https://seekingalpha.com/news/3505928-united-continental-eps-beats-0_11-misses-revenue\" target=\"_blank\">Q3 earnings</a> expectations while raising its FY 2019 EPS forecast to $11.25-$12.25 from previous guidance of $10.50-$12.00, in line with the $11.86 analyst consensus estimate.</li><li>The Q3 performance puts United \"<a href=\"https://www.cnbc.com/2019/10/15/united-airlines-q3-2019-earnings.html\" target=\"_blank\">ahead of pace</a>\" to meet its EPS goal of $11.00-$13.00 by the end of 2020, CEO Oscar Munoz  says.</li><li>Q3's revenue per available seat mile increased 1.7%, in  line with the company's forecast over the summer, while flight capacity rose 1.9% in the quarter, just below the expected 2%-3% improvement.</li><li>However, Q3 cost per available seat mile, which excludes fuel costs, rose 2.1% Y/Y.</li><li>United says it expects to increase capacity by 3.5% this year, below the 4%-6% annual capacity growth it targeted.</li><li>The company does not specify the impact from the grounding of the 737 MAX; the carrier has 14 of the jets and was due to receive another 16 this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505982\" data-linked=\"United Airlines flies after raising full-year earnings guidance\" data-tweet=\"$UAL - United Airlines flies after raising full-year earnings guidance https://seekingalpha.com/news/3505982-united-airlines-flies-after-raising-full-year-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505982-united-airlines-flies-after-raising-full-year-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505956\" data-ts=\"1571172024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FULT\" target=\"_blank\">FULT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505956-fulton-financial-approves-100m-stock-buyback-program\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fulton Financial approves $100M stock buyback program</a></h4><ul><li>Fulton Financial's (NASDAQ:<a href='https://seekingalpha.com/symbol/FULT' title='Fulton Financial Corporation'>FULT</a>) <font color=\"green\">jumps 2.3%</font> in after-hours trading after its board approves <a href=\"https://seekingalpha.com/pr/17663507-fulton-financial-corporation-approves-100-million-stock-repurchase-program\" target=\"_blank\">the repurchase</a> of up to $100M of shares of its common stock, or ~3.9% of Fulton's outstanding shares based on the stock's closing price and number of shares outstanding on Oct. 11, 2019.</li><li>Approval expires Dec. 31, 2020.</li><li>The company repurchased ~$48.0M of its outstanding shares during Q3, which completed the repurchase of shares authorized under the $100M stock buyback program announced in March 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505956\" data-linked=\"Fulton Financial approves $100M stock buyback program\" data-tweet=\"$FULT - Fulton Financial approves $100M stock buyback program https://seekingalpha.com/news/3505956-fulton-financial-approves-100m-stock-buyback-program?source=tweet\" data-url=\"https://seekingalpha.com/news/3505956-fulton-financial-approves-100m-stock-buyback-program\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505955\" data-ts=\"1571171985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCK\" target=\"_blank\">MCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505955-drug-wholesalers-perk-up-on-talks-to-settle-opioid-suits-for-18b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug wholesalers perk up on talks to settle opioid suits for $18B</a></h4><ul><li>Drug distributors McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>), AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) and Cardinal Health (NYSE:<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a>) are up after hours in reaction to the <a href=\"https://www.wsj.com/articles/drug-distributors-in-talks-to-settle-opioid-litigation-for-18-billion-11571170730\" target=\"_blank\">news </a>that they are in talks to settle over 2,000 lawsuits brought by state and local governments over their role in the opioid epidemic. The offer allegedly on the table is $18B over 18 years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505955\" data-linked=\"Drug wholesalers perk up on talks to settle opioid suits for $18B\" data-tweet=\"$MCK $ABC $CAH - Drug wholesalers perk up on talks to settle opioid suits for $18B https://seekingalpha.com/news/3505955-drug-wholesalers-perk-up-on-talks-to-settle-opioid-suits-for-18b?source=tweet\" data-url=\"https://seekingalpha.com/news/3505955-drug-wholesalers-perk-up-on-talks-to-settle-opioid-suits-for-18b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505932\" data-ts=\"1571170888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYTM\" target=\"_blank\">RYTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505932-rhythm-pharma-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rhythm Pharma readies equity offering</a></h4><ul><li>Rhythm Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a>) <a href=\"https://seekingalpha.com/pr/17663502-rhythm-pharmaceuticals-inc-announces-proposed-public-offering\" target=\"_blank\">initiates</a> a public offering of common stock valued up to $150M. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505932\" data-linked=\"Rhythm Pharma readies equity offering\" data-tweet=\"$RYTM - Rhythm Pharma readies equity offering https://seekingalpha.com/news/3505932-rhythm-pharma-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3505932-rhythm-pharma-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505929\" data-ts=\"1571170680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRQR\" target=\"_blank\">PRQR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505929-proqrs-sepofarsen-nabs-rare-pediatric-disease-status-in-u-s-for-lca10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ProQR&#39;s sepofarsen nabs Rare Pediatric Disease status in U.S. for LCA10</a></h4><ul><li>The FDA grants <a href=\"https://seekingalpha.com/pr/17663456-proqr-receives-rare-pediatric-disease-designation-fda-sepofarsen-treatment-lca10\" target=\"_blank\">Rare Pediatric Disease designation</a> for ProQR Therapeutics' (NASDAQ:<a href='https://seekingalpha.com/symbol/PRQR' title='ProQR Therapeutics N.V.'>PRQR</a>) sepofarsen for the treatment of Leber congenital amaurosis type 10 (LCA10).</li><li>Rare Pediatric Disease designation provides for the issuance of a rare pediatric disease priority review voucher following FDA approval. The voucher can be use for accelerated approval of a future application or it can be sold to a third party.</li><li>Shares are down <font color=\"red\">12%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17663466-proqr-announces-proposed-underwritten-public-offering-ordinary-shares\" target=\"_blank\">$50M equity offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505929\" data-linked=\"ProQR&#39;s sepofarsen nabs Rare Pediatric Disease status in U.S. for LCA10\" data-tweet=\"$PRQR - ProQR&#39;s sepofarsen nabs Rare Pediatric Disease status in U.S. for LCA10 https://seekingalpha.com/news/3505929-proqrs-sepofarsen-nabs-rare-pediatric-disease-status-in-u-s-for-lca10?source=tweet\" data-url=\"https://seekingalpha.com/news/3505929-proqrs-sepofarsen-nabs-rare-pediatric-disease-status-in-u-s-for-lca10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505928\" data-ts=\"1571170614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505928-united-continental-eps-beats-0_11-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Continental EPS beats by $0.11, misses on revenue</a></h4><ul><li>United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Airlines Holdings, Inc.'>UAL</a>): Q3 Non-GAAP EPS of $4.07 <font color=\"green\">beats by $0.11</font>; GAAP EPS of $3.99 <font color=\"green\">beats by $0.10</font>.</li><li>Revenue of $11.38B (+3.5% Y/Y) <font color=\"red\">misses by $50M</font>.</li><li>Shares <font color=\"green\">+2.4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17663497-united-airlines-raises-full-year-2019-adjusted-diluted-earnings-per-share-guidance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3505928\" data-linked=\"United Continental EPS beats by $0.11, misses on revenue\" data-tweet=\"$UAL - United Continental EPS beats by $0.11, misses on revenue https://seekingalpha.com/news/3505928-united-continental-eps-beats-0_11-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3505928-united-continental-eps-beats-0_11-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505926\" data-ts=\"1571170570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGM\" target=\"_blank\">MGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505926-mgm-resorts-inks-deal-to-monetize-bellagio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGM Resorts inks deal to monetize Bellagio</a></h4><ul> <li>MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) strikes a <a href=\"https://seekingalpha.com/pr/17663457-mgm-resorts-international-announces-agreement-monetize-bellagio-real-estate-assets\" target=\"_blank\">deal to form a joint venture</a> with Blackstone Real Estate Income Trust (NYSE:<a href='https://seekingalpha.com/symbol/BX' title='The Blackstone Group Inc.'>BX</a>) that values the real estate of Bellagio at $4.25B.</li><li>The company says the deal marks a purchase price multiple of 17.3x rent.</li><li>The JV will acquire the Bellagio real estate and lease it back to a subsidiary of MGM Resorts for initial annual rent of $245M.</li><li>MGM Resorts will receive a 5% equity interest in the joint venture and cash of approximately $4.2B; the transaction is expected to close in Q4.</li><li>Separately, MGM Resorts also announces a deal to <a href=\"https://seekingalpha.com/pr/17663454-mgm-resorts-international-announces-agreement-sell-circus-circus-las-vegas-825-million\" target=\"_blank\">sell Circus Circus Las Vegas</a> to Treasure Island owner Phil Ruffin for $825M.</li> <li>MGM <font color=\"green\">+2.15%</font> after hours to $28.48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505926\" data-linked=\"MGM Resorts inks deal to monetize Bellagio\" data-tweet=\"$MGM $MGP $MGM - MGM Resorts inks deal to monetize Bellagio https://seekingalpha.com/news/3505926-mgm-resorts-inks-deal-to-monetize-bellagio?source=tweet\" data-url=\"https://seekingalpha.com/news/3505926-mgm-resorts-inks-deal-to-monetize-bellagio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505925\" data-ts=\"1571170565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBKR\" target=\"_blank\">IBKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505925-interactive-brokers-q3-includes-47m-loss-on-currency-diversification\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interactive Brokers Q3 includes $47M loss on currency diversification</a></h4><ul><li>Interactive Brokers Group (NASDAQ:<a href='https://seekingalpha.com/symbol/IBKR' title='Interactive Brokers Group, Inc.'>IBKR</a>)<a href=\"https://seekingalpha.com/pr/17663427-interactive-brokers-group-announces-3q2019-results\" target=\"_blank\"> Q3 EPS </a>of 45 cents per share, in line with consensus, falls from 51 cents in the year-ago quarter.</li><li>The results for the quarter include a $47M loss on currency diversification strategy vs. a loss of $24M in the year-ago period; and a $13M mark-to-market loss on its investment in Tiger Brokers.</li><li>IBKR<font color=\"red\"> falls 3.0% </font>in after-hours trading.</li><li>Q3 electronic brokerage segment income before taxes rose 13% Y/Y to $331M; net revenue of $506M rose 14% on higher net interest income and commissions revenue partly offset by lower other income; pretax profit margin of 65% vs. 66% in the year-ago quarter.</li><li>Customer accounts of 666K increased 16% Y/Y and customer equity of $156.6B increased 10%</li><li>Total DARTs for cleared and execution-only customers of 859K rose 13% Y/Y.</li><li>Q3 market making segment income before taxes of $8M, rose 14% Y/Y, primarily due to higher net interest income from the remaining operations.</li><li><a href=\"https://edge.media-server.com/mmc/p/xjumwgue\" target=\"_blank\">Conference call </a>at 4:30 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3505914-interactive-brokers-group-eps-line-beats-revenue\" target=\"_blank\">Interactive Brokers Group EPS in-line, beats on revenue</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3505925\" data-linked=\"Interactive Brokers Q3 includes $47M loss on currency diversification\" data-tweet=\"$IBKR - Interactive Brokers Q3 includes $47M loss on currency diversification https://seekingalpha.com/news/3505925-interactive-brokers-q3-includes-47m-loss-on-currency-diversification?source=tweet\" data-url=\"https://seekingalpha.com/news/3505925-interactive-brokers-q3-includes-47m-loss-on-currency-diversification\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505917\" data-ts=\"1571170129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505917-sleep-numberplus-5-after-double-digit-comp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sleep Number +5% after double-digit comp</a></h4><ul><li>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>) is higher after reporting Q3 profit ahead of even the highest estimate turned in by analysts.</li><li>Comparable sales were up 10% after a flat quarter a year ago.</li><li>Gross margin rose 200 bps to 62.4% of sales vs. 61.6% consensus.</li><li>Looking ahead, the company expects its full-year EPS of $2.45 to $2.75. The outlook includes up to 10% net sales growth for the full-year and a 25% effective income tax rate for Q4.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3505910-sleep-number-eps-beats-0_15-beats-revenue\" target=\"_blank\">Sleep Number EPS beats by $0.15, beats on revenue</a> (Oct. 15)</li><li>SNBR <font color=\"green\">+4.70%</font> AH to $49.05.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505917\" data-linked=\"Sleep Number +5% after double-digit comp\" data-tweet=\"$SNBR - Sleep Number +5% after double-digit comp https://seekingalpha.com/news/3505917-sleep-numberplus-5-after-double-digit-comp?source=tweet\" data-url=\"https://seekingalpha.com/news/3505917-sleep-numberplus-5-after-double-digit-comp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505913\" data-ts=\"1571169941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRNB\" target=\"_blank\">PRNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505913-principia-bio-launches-125m-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Principia Bio launches $125M equity offering</a></h4><ul><li>Principia Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/PRNB' title='Principia Biopharma Inc.'>PRNB</a>) <a href=\"https://seekingalpha.com/pr/17663431-principia-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a $125M public offering of common stock. Price, volume and terms have yet to be announced.</li><li><strong>Update</strong>: Shares down <font color=\"red\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505913\" data-linked=\"Principia Bio launches $125M equity offering\" data-tweet=\"$PRNB - Principia Bio launches $125M equity offering https://seekingalpha.com/news/3505913-principia-bio-launches-125m-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3505913-principia-bio-launches-125m-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505910\" data-ts=\"1571169812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505910-sleep-number-eps-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sleep Number EPS beats by $0.15, beats on revenue</a></h4><ul><li>Sleep Number (NASDAQ:<a href='https://seekingalpha.com/symbol/SNBR' title='Sleep Number Corporation'>SNBR</a>): Q3 GAAP EPS of $0.94 <font color=\"green\">beats by $0.15</font>.</li><li>Revenue of $474.78M (+14.5% Y/Y) <font color=\"green\">beats by $12.72M</font>.</li><li>Shares <font color=\"green\">+7%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17663423-sleep-number-announces-record-third-quarter-2019-results-raises-earnings-outlook\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3505910\" data-linked=\"Sleep Number EPS beats by $0.15, beats on revenue\" data-tweet=\"$SNBR - Sleep Number EPS beats by $0.15, beats on revenue https://seekingalpha.com/news/3505910-sleep-number-eps-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3505910-sleep-number-eps-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505901\" data-ts=\"1571167856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRVR\" target=\"_blank\">JRVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505901-james-riverminus-3_5-suntrust-sees-material-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">James River -3.5% as SunTrust sees &#39;material risk&#39;</a></h4><ul><li>James River Group Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/JRVR' title='James River Group Holdings, Ltd.'>JRVR</a>) <font color=\"red\">drops 3.5% </font>as SunTrust analyst Mark Hughes writes a note saying the insurer faces a \"material risk of further loss development\" in its auto book, which is dominated by Uber.</li><li>James River Group's move to end its relationship with Uber, instead of shift to a more favorable mix over time illustrates the deterioration of the claims environment, Hughes writes.</li><li>Maintains hold rating; price target at $40.</li><li>Quant rating <a href=\"https://seekingalpha.com/symbol/JRVR/ratings/quant-ratings\" target=\"_blank\">Bearish</a>; Sell-Side average rating is <a href=\"https://seekingalpha.com/symbol/JRVR/ratings/sell-side-ratings\" target=\"_blank\">Hold </a>(1 Outperform, 3 Hold, 1 Sell).</li><li><a href=\"https://seekingalpha.com/symbol/JRVR/momentum/performance\" target=\"_blank\">James River Group has declined </a>20% in the past three months vs. financial sector median performance of -2.5%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3504676-james-river-group-minus-9_1-percent-dumping-uber-business\" target=\"_blank\">James River Group -9.1% after dumping Uber business</a> (Oct. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3505901\" data-linked=\"James River -3.5% as SunTrust sees &#39;material risk&#39;\" data-tweet=\"$JRVR - James River -3.5% as SunTrust sees &#39;material risk&#39; https://seekingalpha.com/news/3505901-james-riverminus-3_5-suntrust-sees-material-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3505901-james-riverminus-3_5-suntrust-sees-material-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505898\" data-ts=\"1571167457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGG\" target=\"_blank\">NGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505898-u-k-regulator-cuts-national-grids-hinkley-point-funding-80m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.K. regulator cuts National Grid&#39;s Hinkley Point funding by £80M</a></h4><ul><li>U.K. energy market regulator Ofgem says it will <a href=\"https://www.reuters.com/article/us-britain-nuclear-hinkley-national-grid/uk-regulator-looks-to-cut-costs-of-new-hinkley-point-grid-link-idUSKBN1WU0LX\" target=\"_blank\">grant £637M</a> ($803M) to National Grid (<a href='https://seekingalpha.com/symbol/NGG' title='National Grid plc'>NGG</a> <font color='green'>+2.6%</font>) for building the transmission link for the Hinkley Point C nuclear plant, lower than the company's initial request for £717M.</li><li>Ofgem says it cut the allowed funding after rejecting £40M in \"risk funding\" that National Grid Energy Transmission had sought to be included in the upfront cost of the link, but the company could be in a position to seek additional funding for some risks such as extreme weather or flooding if they are efficiently managed and take place during construction.</li><li>The regulator's move comes after EDF said last month that its Hinkley Point C nuclear plant could cost as much as £2.9B more than its last estimate and face further delays.</li><li>Separately, NGG says it is <a href=\"https://www.reuters.com/article/national-grid-natgas/national-grid-says-it-will-reconnect-natgas-customers-after-ny-order-idUSL2N26Z0N8\" target=\"_blank\">taking steps to reconnect</a> more than 1,000 natural gas customers in New York City and Long Island following a <a href=\"https://seekingalpha.com/news/3505371-national-grid-told-turn-new-york-gas-service-faces-millions-fines\" target=\"_blank\">state order</a> after the company previously refused to reinstate service.</li><li>Also, the Massachusetts Department of Public Utilities has <a href=\"https://www.greentechmedia.com/articles/read/massachusetts-regulators-audit-national-grid-over-concerns-with-management#gs.ae9yqe\" target=\"_blank\">launched an investigation</a> into the utility, promising to \"address the efficiencies  of operations and productivity of National Grid's management and  personnel.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3505898\" data-linked=\"U.K. regulator cuts National Grid&#39;s Hinkley Point funding by £80M\" data-tweet=\"$NGG - U.K. regulator cuts National Grid&#39;s Hinkley Point funding by £80M https://seekingalpha.com/news/3505898-u-k-regulator-cuts-national-grids-hinkley-point-funding-80m?source=tweet\" data-url=\"https://seekingalpha.com/news/3505898-u-k-regulator-cuts-national-grids-hinkley-point-funding-80m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505897\" data-ts=\"1571167058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505897-facebooks-libra-sets-membership-after-payment-firm-exits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook&#39;s Libra sets membership after payment-firm exits</a></h4><ul>   <li>The founding members of the Libra Association -- built to manage Facebook's (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+3%</font>) proposed digital currency -- met in Geneva to settle on membership and a charter, though with most of its payment partners missing after a sudden exodus.</li>    <li><a href=\"https://www.cnbc.com/2019/10/14/facebook-forms-its-cryptocurrency-council-after-key-backers-drop-out.html\" target=\"_blank\">Twenty-one founding members</a> remain from an original 28, including Uber, Lyft, Spotify, Coinbase, Vodafone and PayU.</li>    <li>Just one business day before the meeting, <a href=\"https://seekingalpha.com/news/3505362-visa-exits-facebooks-libra-amid-rush-departures\" target=\"_blank\">Visa, Mastercard, Stripe, eBay and Mercado Pago dropped out</a> -- joining <a href=\"https://seekingalpha.com/news/3504078-paypal-drops-facebooks-libra-project\" target=\"_blank\">PayPal's exit the week before</a>, and leaving PayU as Libra's only payment-company member. And yesterday Booking dropped out as well.</li>    <li>Facebook's image problem has <a href=\"https://www.wsj.com/articles/facebooks-currency-already-was-devalued-11571069469?mod=searchresults&amp;page=1&amp;pos=4\" target=\"_blank\">been a problem for Libra</a> from the start, the <i>WSJ's</i> Heard on the Street notes, pointing out Libra chief David Marcus was hauled before Congress to testify just a month after announcement.</li>    <li>MoffettNathanson sees a potential downfall in the payments exodus, as those companies bring the things Facebook doesn't already have: \"essential, deep payments expertise, trusted payments brands, global acceptance and settlement networks, and relationships with every major financial institution, government, and regulatory body around the world.\u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505897\" data-linked=\"Facebook&#39;s Libra sets membership after payment-firm exits\" data-tweet=\"$FB - Facebook&#39;s Libra sets membership after payment-firm exits https://seekingalpha.com/news/3505897-facebooks-libra-sets-membership-after-payment-firm-exits?source=tweet\" data-url=\"https://seekingalpha.com/news/3505897-facebooks-libra-sets-membership-after-payment-firm-exits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505894\" data-ts=\"1571166705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505894-uber-grubhub-gain-wendys-eyes-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber, GrubHub gain as Wendy&#39;s eyes deals</a></h4><ul><li>Wendy's (NASDAQ:<a href='https://seekingalpha.com/symbol/WEN' title='The Wendy&#39;s Company'>WEN</a>) <a href=\"https://finance.yahoo.com/news/wendys-goes-digital-partners-ubereats-grubhub-144942666.html\" target=\"_blank\">wants to add</a> Uber Eats (NYSE:<a href='https://seekingalpha.com/symbol/UBER' title='Uber Technologies, Inc.'>UBER</a>) and GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>) as delivery partners before the end of the year, CEO Todd Penegor tells Yahoo Finance.</li><li>The company currently has an exclusive agreement with DoorDash (<a href='https://seekingalpha.com/symbol/DOORD' title='DoorDash'>DOORD</a>) but, thanks to a tech upgrade, Wendy's is now ready to welcome more partners.</li><li>Penegor thinks Wendy's digital sales could reach 10% of total business by 2024, up from the current 2%.</li><li>Uber shares are <font color=\"green\">up 3.1%</font>, GRUB is <font color=\"green\">up 3.1%</font>, and WEN is <font color=\"green\">up 1.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505894\" data-linked=\"Uber, GrubHub gain as Wendy&#39;s eyes deals\" data-tweet=\"$WEN $UBER $GRUB - Uber, GrubHub gain as Wendy&#39;s eyes deals https://seekingalpha.com/news/3505894-uber-grubhub-gain-wendys-eyes-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3505894-uber-grubhub-gain-wendys-eyes-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505893\" data-ts=\"1571166126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505893-softbank-hires-bankers-for-wework-cash-issue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank hires bankers for WeWork cash issue</a></h4><ul><li>SoftBank (<a href='https://seekingalpha.com/symbol/SFTBF' title='SoftBank Group Corp.'>OTCPK:SFTBF</a>,<a href='https://seekingalpha.com/symbol/SFTBY' title='SoftBank Group Corp.'>OTCPK:SFTBY</a>)<a href=\"https://www.bloomberg.com/news/articles/2019-10-15/softbank-taps-houlihan-lokey-for-wework-restructuring-advice\" target=\"_blank\"> has hired</a> Houlihan Lokey to explore options for easing WeWork's (<a href='https://seekingalpha.com/symbol/WE' title='The We Company'>WE</a>) cash troubles, according to Bloomberg sources.</li><li>Leases could be cut as Houlihan works to trim liabilities.</li><li>SoftBank is WeWork's largest shareholder and has offered to buy a controlling stake, but a report yesterday suggested WE <a href=\"https://seekingalpha.com/news/3505659-wework-favoring-jpmorgan-rescue-softbank-bloomberg\" target=\"_blank\">preferred an offer</a> from JPMorgan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505893\" data-linked=\"SoftBank hires bankers for WeWork cash issue\" data-tweet=\"$SFTBF $SFTBY $WE - SoftBank hires bankers for WeWork cash issue https://seekingalpha.com/news/3505893-softbank-hires-bankers-for-wework-cash-issue?source=tweet\" data-url=\"https://seekingalpha.com/news/3505893-softbank-hires-bankers-for-wework-cash-issue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505891\" data-ts=\"1571165561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505891-gluu-cih-resn-and-dgly-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GLUU, CIH, RESN and DGLY among tech movers</a></h4><ul><li><strong>Gainers: </strong>Gridsum Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding Inc.'>GSUM</a>) <font color=\"green\">+16%</font>. JMU Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"green\">+16%</font>. AGM Group Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a>) <font color=\"green\">+13%</font>. Technical Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corporation'>TCCO</a>) <font color=\"green\">+12%</font>. Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"red\">-11%</font>. Internap Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"red\">-8%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant Inc.'>RESN</a>) <font color=\"red\">-8%</font>. China Index Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a>) <font color=\"red\">-7%</font>. Digital Ally (NASDAQ:<a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505891\" data-linked=\"GLUU, CIH, RESN and DGLY among tech movers\" data-tweet=\"$GSUM $JMU $AGMH - GLUU, CIH, RESN and DGLY among tech movers https://seekingalpha.com/news/3505891-gluu-cih-resn-and-dgly-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505891-gluu-cih-resn-and-dgly-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505889\" data-ts=\"1571164508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTU\" target=\"_blank\">BTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505889-peabody-to-close-illinois-coal-mine-processing-plant\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peabody to close Illinois coal mine, processing plant</a></h4><ul><li>Peabody Energy (<a href='https://seekingalpha.com/symbol/BTU' title='Peabody Energy Corporation'>BTU</a> <font color=\"green\">+2.3%</font>) says it plans to <a href=\"https://www.wsj.com/articles/peabody-to-close-coal-mine-amid-price-drop-11571156249\" target=\"_blank\">shutter its Wildcat Hills mine</a> and coal processing facility in Illinois due to \"uneconomic mining conditions,\" resulting in ~225 layoffs.</li><li>The mine, which sold 1.4M tons of coal last year and has been open since 2006, is scheduled to close in December.</li><li>The closure is the latest shutdown of coal operations amid a drop in prices; meanwhile, export prices of premium coking coal from the east coast to an average of $158/mt during Q3 from ~$200/mt for the first half of the year.</li><li>Seaport Global Securities recently cut its Q3 earnings estimates for BTU due to reduced expectations for coal prices; BTU <a href=\"https://seekingalpha.com/news/3497274-peabody-energy-sees-q3-hurt-weaker-demand-lower-prices\" target=\"_blank\">warned last month</a> that its Q3 earnings would come in substantially lower than Q2, due in part lower pricing and demand in its seaborne thermal and metallurgical coal segments.</li><li>ETF: <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3505889\" data-linked=\"Peabody to close Illinois coal mine, processing plant\" data-tweet=\"$BTU $KOL - Peabody to close Illinois coal mine, processing plant https://seekingalpha.com/news/3505889-peabody-to-close-illinois-coal-mine-processing-plant?source=tweet\" data-url=\"https://seekingalpha.com/news/3505889-peabody-to-close-illinois-coal-mine-processing-plant\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505885\" data-ts=\"1571162731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUM\" target=\"_blank\">YUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505885-taco-bell-recalls-2_3m-lbs-of-beef\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taco Bell recalls 2.3M lbs. of beef</a></h4><ul><li>Yum! Brands (<a href='https://seekingalpha.com/symbol/YUM' title='YUM! Brands, Inc.'>YUM</a> <font color='red'>-1.4%</font>) turns lower after Taco Bell said it has <a href=\"https://www.cnbc.com/2019/10/15/taco-bell-removes-2point3-million-pounds-of-seasoned-beef.html\" target=\"_blank\">recalled 2.3M lbs. of seasoned beef</a> after a customer discovered a metal shaving in an order.</li><li>The company says all affected restaurants in 21 states across the eastern  Midwest, northern Southeast and Northeast regions of the U.S. have removed and  discarded the beef.</li><li>The U.S. Department of Agriculture says there have been no confirmed reports of  adverse reactions from consuming Taco Bell's beef.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505885\" data-linked=\"Taco Bell recalls 2.3M lbs. of beef\" data-tweet=\"$YUM - Taco Bell recalls 2.3M lbs. of beef https://seekingalpha.com/news/3505885-taco-bell-recalls-2_3m-lbs-of-beef?source=tweet\" data-url=\"https://seekingalpha.com/news/3505885-taco-bell-recalls-2_3m-lbs-of-beef\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505883\" data-ts=\"1571162498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505883-westwater-resources-and-ring-energy-among-energy-materials-gainers-yuma-energy-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westwater Resources and Ring Energy among Energy/Materials gainers; Yuma Energy and SAExploration among losers</a></h4><ul><li><b>Gainers: </b>Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"green\">+81%</font>. Ring Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/REI' title='Ring Energy, Inc.'>REI</a>) <font color=\"green\">+15%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+12%</font>. Laredo Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum, Inc.'>LPI</a>) <font color=\"green\">+8%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-21%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-14%</font>. Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia Limited'>SNDE</a>) <font color=\"red\">-11%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-9%</font>. Mexco Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505883\" data-linked=\"Westwater Resources and Ring Energy among Energy/Materials gainers; Yuma Energy and SAExploration among losers\" data-tweet=\"$WWR $REI $KEG - Westwater Resources and Ring Energy among Energy/Materials gainers; Yuma Energy and SAExploration among losers https://seekingalpha.com/news/3505883-westwater-resources-and-ring-energy-among-energy-materials-gainers-yuma-energy-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3505883-westwater-resources-and-ring-energy-among-energy-materials-gainers-yuma-energy-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505879\" data-ts=\"1571161504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ON\" target=\"_blank\">ON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505879-on-aimotive-collab-on-auto-platforms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ON, AImotive collab on auto platforms</a></h4><ul><li>ON Semi (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='green'>+3.3%</font>) and AImotive <a href=\"https://seekingalpha.com/pr/17662997-semiconductor-aimotive-announce-collaboration-future-sensor-fusion-hardware-platforms\" target=\"_blank\">will team</a> to prototype sensor fusion platforms for auto applications.</li><li>The companies plan to create a series of hardware platform demos combining ON's HD camera and radar sensor and pre-processor chipsets with AImotive's AI-based perception algorithms and simulation capabilities.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505879\" data-linked=\"ON, AImotive collab on auto platforms\" data-tweet=\"$ON - ON, AImotive collab on auto platforms https://seekingalpha.com/news/3505879-on-aimotive-collab-on-auto-platforms?source=tweet\" data-url=\"https://seekingalpha.com/news/3505879-on-aimotive-collab-on-auto-platforms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505876\" data-ts=\"1571160413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505876-youdao-offering-5_6m-ads-15-18-in-ipo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Youdao offering 5.6M ADS at $15-$18 in IPO</a></h4><ul>   <li>Youdao (<a href='https://seekingalpha.com/symbol/DAO' title='Youdao'>DAO</a>), the education unit of Chinese videogame maker NetEase (<a href=\"http://seekingalpha.com/symbol/NTES\" target=\"_blank\">NTES</a> <font color=\"green\">+2.6%</font>), has <a href=\"https://www.sec.gov/Archives/edgar/data/1781753/000119312519267549/0001193125-19-267549-index.htm\" target=\"_blank\">amended its initial public offering registration</a> to detail size and price range.</li>    <li>The company will offer 5.6M American Depositary Shares in a range of $15-$18 each.</li>    <li>It's also added Credit Suisse as an underwriter, along with Citigroup and Morgan Stanley.</li>    <li>Youdao <a href=\"https://seekingalpha.com/news/3502751-netease-education-unit-youdao-files-u-s-ipo\" target=\"_blank\">initially filed</a> on Sept. 30 with a placeholder registration for $300M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505876\" data-linked=\"Youdao offering 5.6M ADS at $15-$18 in IPO\" data-tweet=\"$DAO $NTES - Youdao offering 5.6M ADS at $15-$18 in IPO https://seekingalpha.com/news/3505876-youdao-offering-5_6m-ads-15-18-in-ipo?source=tweet\" data-url=\"https://seekingalpha.com/news/3505876-youdao-offering-5_6m-ads-15-18-in-ipo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505873\" data-ts=\"1571160088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505873-centurylink-expands-connection-to-google-cloud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink expands connection to Google Cloud</a></h4><ul>   <li>CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color=\"green\">+3.5%</font>) has expanded its on-demand network connectivity to <a href=\"https://seekingalpha.com/pr/17662300-centurylink-expands-demand-network-connectivity-google-cloud-platform\" target=\"_blank\">Google Cloud Platform</a>.</li>    <li>The company has broadened its Cloud Connect Dynamic Connections service to Google's offering in order to enable self-serve dedicated network connectivity through its thousands of endpoints worldwide.</li>    <li>CenturyLink's portal and API offer real-time control over hybrid cloud networking using private Ethernet, and features pay-as-you-go billing.</li>    <li>Its global broadcast fiber network, Vyvx Cloud Connect, also offers access to Google Cloud Platform.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505873\" data-linked=\"CenturyLink expands connection to Google Cloud\" data-tweet=\"$CTL - CenturyLink expands connection to Google Cloud https://seekingalpha.com/news/3505873-centurylink-expands-connection-to-google-cloud?source=tweet\" data-url=\"https://seekingalpha.com/news/3505873-centurylink-expands-connection-to-google-cloud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505869\" data-ts=\"1571159203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505869-general-motors-uaw-reach-deal-on-temp-workers-ny-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Motors, UAW reach deal on temp workers - NY Post</a></h4><ul><li>General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='green'>+2.3%</font>) and the United Auto Workers have <a href=\"https://nypost.com/2019/10/15/general-motors-uaw-reach-key-agreement-on-temp-workers/\" target=\"_blank\">tentatively reached an agreement</a> that would give temporary workers a clear path to becoming full-time employees, helping pave the way to ending the strike, <em>NY Post</em> reports.</li><li>GM will give all temporary workers - who make $15-$19/hour and have fewer benefits - the opportunity to become full-time  workers after three years of consecutive service, according to the report, which also says the change would affect 4K UAW workers at GM across the U.S.</li><li>The apparent breakthrough comes as negotiations are said to have made progress and CEO Mary Barra met with UAW negotiators <a href=\"https://seekingalpha.com/news/3505795-barra-joins-negotiations-two-sides-reportedly-move-closer\" target=\"_blank\">this morning</a>, and a full agreement could come as soon as tonight or tomorrow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505869\" data-linked=\"General Motors, UAW reach deal on temp workers - NY Post\" data-tweet=\"$GM - General Motors, UAW reach deal on temp workers - NY Post https://seekingalpha.com/news/3505869-general-motors-uaw-reach-deal-on-temp-workers-ny-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3505869-general-motors-uaw-reach-deal-on-temp-workers-ny-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505865\" data-ts=\"1571158937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505865-titan-international-and-rada-electronic-among-industrial-gainers-ideal-power-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan International and RADA Electronic among industrial gainers; Ideal Power among losers</a></h4><ul><li><b>Gainers: </b>Installed Building Products (NYSE:<a href='https://seekingalpha.com/symbol/IBP' title='Installed Building Products, Inc.'>IBP</a>) <font color=\"green\">+6%</font>. BMC Stock Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BMCH' title='BMC Stock Holdings, Inc.'>BMCH</a>) <font color=\"green\">+6%</font>. Titan International (NYSE:<a href='https://seekingalpha.com/symbol/TWI' title='Titan International, Inc.'>TWI</a>) <font color=\"green\">+5%</font>. RADA Electronic Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/RADA' title='RADA Electronic Industries Ltd.'>RADA</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-36%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-18%</font>. ReTo Eco-Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/RETO' title='ReTo Eco-Solutions, Inc.'>RETO</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505865\" data-linked=\"Titan International and RADA Electronic among industrial gainers; Ideal Power among losers\" data-tweet=\"$IBP $BMCH $TWI - Titan International and RADA Electronic among industrial gainers; Ideal Power among losers https://seekingalpha.com/news/3505865-titan-international-and-rada-electronic-among-industrial-gainers-ideal-power-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505865-titan-international-and-rada-electronic-among-industrial-gainers-ideal-power-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505863\" data-ts=\"1571158501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505863-drive-shack-leads-financial-gainers-puyi-and-flexshopper-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drive Shack leads financial gainers; Puyi and FlexShopper among losers</a></h4><ul><li><b>Gainers:</b> Drive Shack (NYSE:<a href='https://seekingalpha.com/symbol/DS' title='Drive Shack Inc.'>DS</a>) <font color=\"green\">+9%</font>. Plumas Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PLBC' title='Plumas Bancorp'>PLBC</a>) <font color=\"green\">+9%</font>. MDJM (NASDAQ:<a href='https://seekingalpha.com/symbol/MDJH' title='MDJM Ltd.'>MDJH</a>) <font color=\"green\">+8%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"green\">+7%</font>. Lloyds Banking Group (NYSE:<a href='https://seekingalpha.com/symbol/LYG' title='Lloyds Banking Group plc'>LYG</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-15%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-12%</font>. FlexShopper (NASDAQ:<a href='https://seekingalpha.com/symbol/FPAY' title='FlexShopper, Inc.'>FPAY</a>) <font color=\"red\">-6%</font>. Qiwi (NASDAQ:<a href='https://seekingalpha.com/symbol/QIWI' title='Qiwi plc'>QIWI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505863\" data-linked=\"Drive Shack leads financial gainers; Puyi and FlexShopper among losers\" data-tweet=\"$DS $PLBC $MDJH - Drive Shack leads financial gainers; Puyi and FlexShopper among losers https://seekingalpha.com/news/3505863-drive-shack-leads-financial-gainers-puyi-and-flexshopper-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505863-drive-shack-leads-financial-gainers-puyi-and-flexshopper-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505861\" data-ts=\"1571158093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505861-sprint-sell-spectrum-merger-fails-bofa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint could sell spectrum if merger fails - BofA</a></h4><ul>   <li>If a merger with T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+1.3%</font>) fails to the opposing multistate lawsuit, Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+1.9%</font>) could look at selling part of its spectrum as one of a number of post-deal scenarios, Bank of America says.</li>    <li>Notwithstanding <a href=\"https://seekingalpha.com/news/3504838-mississippi-deal-shrinks-t-mobile-sprint-lawsuit\" target=\"_blank\">momentum in Mississippi</a> and possibly other states, a settlement of the suit is unlikely so long as New York and California have their concerns, analyst David Barden says (echoing <a href=\"https://seekingalpha.com/news/3505075-t-mobile-state-deal-positive-new-york-remains-wells-fargo\" target=\"_blank\">Wells Fargo</a>).</li>    <li>Sprint could sell half of its 2.5 GHz spectrum and see aggressive bidding from T-Mobile and Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"green\">+0.9%</font>) that could raise $20B, he says -- a move that would halve Sprint's debt and save $1.25B in annual interest.</li>    <li>Or it could form a joint capital/spectrum venture with T-Mobile, or seek (unlikely) help from parent SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color=\"green\">+1.8%</font>).</li>    <li>The deal's breakup would likely mean downside not only for Sprint and T-Mobile but also tower stocks like American Tower (<a href=\"http://seekingalpha.com/symbol/AMT\" target=\"_blank\">AMT</a> <font color=\"red\">-1.2%</font>), Crown Castle (<a href=\"http://seekingalpha.com/symbol/CCI\" target=\"_blank\">CCI</a> <font color=\"red\">-1%</font>) and SBA (<a href=\"http://seekingalpha.com/symbol/SBAC\" target=\"_blank\">SBAC</a> <font color=\"red\">-1%</font>), he says, while AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+1.1%</font>) and Verizon could benefit with a weakened Sprint struggling and potential entrant Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+2.1%</font>) benched.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505861\" data-linked=\"Sprint could sell spectrum if merger fails - BofA\" data-tweet=\"$TMUS $S $VZ - Sprint could sell spectrum if merger fails - BofA https://seekingalpha.com/news/3505861-sprint-sell-spectrum-merger-fails-bofa?source=tweet\" data-url=\"https://seekingalpha.com/news/3505861-sprint-sell-spectrum-merger-fails-bofa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505860\" data-ts=\"1571158090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505860-apha-ctst-auph-and-abeo-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APHA, CTST, AUPH and ABEO among midday movers</a></h4><ul><li><strong>Gainers: </strong>Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"green\">+108%</font>. TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"green\">+74%</font>. Reata Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals, Inc.'>RETA</a>) <font color=\"green\">+60%</font>. Ra Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/RMED' title='Ra Medical Systems, Inc.'>RMED</a>) <font color=\"green\">+25%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+25%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"green\">+25%</font>. CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"green\">+24%</font>. JanOne (NASDAQ:<a href='https://seekingalpha.com/symbol/JAN' title='JanOne Inc.'>JAN</a>) <font color=\"green\">+21%</font>. Aurinia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a>) <font color=\"green\">+20%</font>. JMU Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"green\">+20%</font>.</li> <li><strong>Losers: </strong>Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"red\">-49%</font>. NF Energy Saving Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-38%</font>. Ideal Power (NASDAQ:<a href='https://seekingalpha.com/symbol/IPWR' title='Ideal Power Inc.'>IPWR</a>) <font color=\"red\">-21%</font>. Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-19%</font>. Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"red\">-15%</font>. SAExploration Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"red\">-14%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-13%</font>. Luokung Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/LKCO' title='Luokung Technology Corp.'>LKCO</a>) <font color=\"red\">-11%</font>. Ruhnn Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RUHN' title='Ruhnn Holding Limited'>RUHN</a>) <font color=\"red\">-11%</font>. Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia Limited'>SNDE</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505860\" data-linked=\"APHA, CTST, AUPH and ABEO among midday movers\" data-tweet=\"$WWR $PETZ $RETA - APHA, CTST, AUPH and ABEO among midday movers https://seekingalpha.com/news/3505860-apha-ctst-auph-and-abeo-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505860-apha-ctst-auph-and-abeo-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505856\" data-ts=\"1571157977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLHC\" target=\"_blank\">DLHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505856-dlhplus-5_3-on-preliminary-results-for-fy-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DLH +5.3% on preliminary results for FY 2019</a></h4><ul><li>DLH Holdings (<a href='https://seekingalpha.com/symbol/DLHC' title='DLH Holdings Corp.'>DLHC</a> <font color=\"green\">+5.3%</font>) <a href=\"https://seekingalpha.com/pr/17662221-dlh-announces-preliminary-results-fiscal-year-end-2019\" target=\"_blank\">announced</a> selected preliminary results for the FY 2019; where unaudited revenue is expected to be ~$159M, including ~$24M from the recently acquired Social &amp; Scientific Systems.</li><li>The Company paid down its senior bank debt to $56M, representing an aggregate reduction of $14M since the S3 transaction closed.</li><li>The 12-month trailing leverage ratio for the Company is expected to be below 3.0 times consolidated EBITDA.</li><li>DLH will release its fourth quarter financial results for the period ended September 30, 2019 on December 11, 2019 after the market close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505856\" data-linked=\"DLH +5.3% on preliminary results for FY 2019\" data-tweet=\"$DLHC - DLH +5.3% on preliminary results for FY 2019 https://seekingalpha.com/news/3505856-dlhplus-5_3-on-preliminary-results-for-fy-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3505856-dlhplus-5_3-on-preliminary-results-for-fy-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505852\" data-ts=\"1571157137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PHAS\" target=\"_blank\">PHAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505852-phasebio-up-9-on-start-of-mid-stage-study-of-lead-drug-pb2452\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PhaseBio up 9% on start of mid-stage study of lead drug PB2452</a></h4><ul><li>Thinly traded micro cap PhaseBio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a> <font color=\"green\">+8.6%</font>) is up on below-average volume in reaction to its <a href=\"https://seekingalpha.com/pr/17662175-phasebio-announces-first-patient-dosed-phase-2b-clinical-trial-pb2452-reversal-antiplatelet\" target=\"_blank\">announcement</a> that the first patient has been dosed in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT04122170?lead=phasebio&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2b clinical trial</a> evaluating lead candidate <a href=\"https://phasebio.com/pipeline/pb2452/\" target=\"_blank\">PB2452</a> as a reversing agent of blood thinner ticagrelor (AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"green\">+0.4%</font>) <a href=\"https://www.brilinta.com/\" target=\"_blank\">Brilinta</a>) in major bleeding and urgent surgery situations.</li><li>The study will assess the combination of PB2452 and low-dose aspirin in ~200 subjects ages 50 - 80, a group that the company says resembles the population most likely to be treated with ticagrelor.</li><li>The primary endpoint is the reversal of the antiplatelet effects of ticagrelor four hours after the start of infusion of PB2452 as measured by Accriva Diagnostics' <a href=\"http://www.accriva.com/uploads/literature/vn1016en-web-01.pdf\" target=\"_blank\">VerifyNow PRUTest</a> which measures platelet reactivity.</li><li>The estimated completion date is June 2022.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505852\" data-linked=\"PhaseBio up 9% on start of mid-stage study of lead drug PB2452\" data-tweet=\"$PHAS $AZN - PhaseBio up 9% on start of mid-stage study of lead drug PB2452 https://seekingalpha.com/news/3505852-phasebio-up-9-on-start-of-mid-stage-study-of-lead-drug-pb2452?source=tweet\" data-url=\"https://seekingalpha.com/news/3505852-phasebio-up-9-on-start-of-mid-stage-study-of-lead-drug-pb2452\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505849\" data-ts=\"1571156474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLD\" target=\"_blank\">RGLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505849-royal-gold-appoints-libner-new-cfo-isto-coo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royal Gold appoints Libner as new CFO, Isto as COO</a></h4><ul><li>Royal Gold (<a href='https://seekingalpha.com/symbol/RGLD' title='Royal Gold, Inc.'>RGLD</a> <font color='red'>-6.2%</font>) <a href=\"https://seekingalpha.com/pr/17662975-royal-gold-announces-senior-management-appointments\" target=\"_blank\">promotes</a> current Controller and Treasurer Paul Libner as the company's new CFO and Treasurer as well as VP Operations Mark Isto as its new COO.</li><li>The appointments will take effect on Jan. 2, as current CFO William Heissenbuttel ascends to the position of President and CEO.</li><li>Libner joined RGLD in 2004 and has more than 20 years of experience working in various financial and accounting roles.</li><li>Isto has 35 years of experience in mining engineering and mine management; he joined RGLD in 2015 after spending time at Placer Dome, Kinross Gold and First Nickel.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505849\" data-linked=\"Royal Gold appoints Libner as new CFO, Isto as COO\" data-tweet=\"$RGLD - Royal Gold appoints Libner as new CFO, Isto as COO https://seekingalpha.com/news/3505849-royal-gold-appoints-libner-new-cfo-isto-coo?source=tweet\" data-url=\"https://seekingalpha.com/news/3505849-royal-gold-appoints-libner-new-cfo-isto-coo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505838\" data-ts=\"1571155471\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505838-abeona-up-25-on-positive-long-term-data-on-rdeb-cell-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona up 25% on positive long-term data on RDEB cell therapy</a></h4><ul><li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"green\">+25.3%</font>) is up on modestly higher volume on the heels of <a href=\"https://seekingalpha.com/pr/17662728-abeona-therapeutics-announces-publication-positive-long-term-data-phase-1-2a-clinical-trial\" target=\"_blank\">long-term results</a> from a Phase 1/2a clinical trial evaluating autologous gene-corrected cell therapy EB-101 in patients with a rare inherited skin blistering disorder called recessive dystrophic epidermolysis bullosa &#40;RDEB&#41;.</li><li>Three years after treatment with EB-101, the majority of patients experienced sustained wound healing, with 80% (n=16/20) achieving at least 50% healing and 70% (n=14/20) achieving at least 75% healing, superior to the 17% of untreated patients who experienced at least 50% healing at year 2 (year 3 results not provided).</li><li>50% or greater wound healing was associated with no pain (n=0/16) or itch (n=0/16) three years after treatment compared to 53% (n=20/38) and 61% (n=23/38), respectively, at baseline.</li><li>No new safety signals were observed and no replication competent virus was present at any time point.</li><li>A Phase 3 trial, VIITAL, is next up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505838\" data-linked=\"Abeona up 25% on positive long-term data on RDEB cell therapy\" data-tweet=\"$ABEO - Abeona up 25% on positive long-term data on RDEB cell therapy https://seekingalpha.com/news/3505838-abeona-up-25-on-positive-long-term-data-on-rdeb-cell-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3505838-abeona-up-25-on-positive-long-term-data-on-rdeb-cell-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505830\" data-ts=\"1571155306\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505830-electrameccanica-vehicles-and-calyxt-among-consumer-gainers-losers-none\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Electrameccanica Vehicles and Calyxt among consumer gainers; Losers none</a></h4><ul><li><b>Gainers: </b>TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"green\">+46%</font>. Electrameccanica Vehicles (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLO' title='Electrameccanica Vehicles Corp.'>SOLO</a>) <font color=\"green\">+8%</font>. Calyxt (NASDAQ:<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a>) <font color=\"green\">+8%</font>. Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"green\">+7%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>None</li></ul><div class=\"tiny-share-widget\" data-id=\"3505830\" data-linked=\"Electrameccanica Vehicles and Calyxt among consumer gainers; Losers none\" data-tweet=\"$PETZ $SOLO $CLXT - Electrameccanica Vehicles and Calyxt among consumer gainers; Losers none https://seekingalpha.com/news/3505830-electrameccanica-vehicles-and-calyxt-among-consumer-gainers-losers-none?source=tweet\" data-url=\"https://seekingalpha.com/news/3505830-electrameccanica-vehicles-and-calyxt-among-consumer-gainers-losers-none\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505835\" data-ts=\"1571155296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDP\" target=\"_blank\">MDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505835-meredith-hires-kwon-chief-strategy-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meredith hires Kwon as chief strategy officer</a></h4><ul>    <li>Meredith (<a href=\"http://seekingalpha.com/symbol/MDP\" target=\"_blank\">MDP</a> <font color=\"green\">+1.7%</font>) has added Daphne Kwon as its new <a href=\"https://seekingalpha.com/pr/17663005-daphne-kwon-join-meredith-corporation-chief-strategy-officer\" target=\"_blank\">chief strategy officer</a>.</li>    <li>The move is effective Nov. 4.</li>    <li>She fills a role vacated by Catherine Levene, who earlier this year was promoted to chief digital officer.</li>    <li>Kwon launched several digital TV networks while at Disney, and was initial chief financial officer at Oxygen Media.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505835\" data-linked=\"Meredith hires Kwon as chief strategy officer\" data-tweet=\"$MDP - Meredith hires Kwon as chief strategy officer https://seekingalpha.com/news/3505835-meredith-hires-kwon-chief-strategy-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3505835-meredith-hires-kwon-chief-strategy-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505828\" data-ts=\"1571154915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPI\" target=\"_blank\">LPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505828-laredo-petroleum-reports-q3-production-above-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Laredo Petroleum reports Q3 production above guidance</a></h4><ul><li>Laredo Petroleum (<a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum, Inc.'>LPI</a> <font color='green'>+3.1%</font>) says it <a href=\"https://seekingalpha.com/pr/17662356-laredo-petroleum-announces-third-quarter-2019-production-results-updates-full-year-2019\" target=\"_blank\">exceeded its guidance</a> for both oil and total production in Q3, producing 27.8K bbl/day of oil and 81.9K boe/day overall, while also reducing well costs to $660 per lateral foot through efficiencies and service cost reductions.</li><li>For FY 2019, LPI lifts production guidance to 28.1K bbl/day of oil and 79K boe/day overall, and increases expected full-year cash flow by $65M from its May forecast.</li><li>The company now believes it will deliver $40M of free cash flow in 2019 while maintaining its dedicated completions crew for the rest of the year.</li><li>LPI now expects to be cash flow positive in both 2020 and 2021 and grow oil production each year from the estimated higher updated FY 2019 oil production base.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505828\" data-linked=\"Laredo Petroleum reports Q3 production above guidance\" data-tweet=\"$LPI - Laredo Petroleum reports Q3 production above guidance https://seekingalpha.com/news/3505828-laredo-petroleum-reports-q3-production-above-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505828-laredo-petroleum-reports-q3-production-above-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505815\" data-ts=\"1571154057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTST\" target=\"_blank\">CTST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505815-canntrust-up-22-on-progress-to-address-compliance-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CannTrust up 22% on progress to address compliance issues</a></h4><ul><li>Cannabis producer CannTrust (<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a> <font color=\"green\">+22.1%</font>) is up on 60% higher volume in reaction to its <a href=\"https://seekingalpha.com/pr/17661514-canntrust-advances-plan-towards-regulatory-compliance\" target=\"_blank\">announcement </a>that it is making \"significant progress\" on getting its suspended licenses in Canada reinstated.</li><li>It <a href=\"https://seekingalpha.com/news/3499933-canntrust-license-suspended-canada-shares-3-percent\" target=\"_blank\">received </a>a Notice of License Suspension last month from Health Canada citing a range of compliance issues.</li><li>The company says it is implementing measures to ensure that cannabis will be produced and distributed only as authorized, to recover unauthorized cannabis, to improve employees' knowledge of and compliance with regulations and improve record-keeping.</li><li>Cannabis players are enjoying a surge in buying after Aphria <a href=\"https://seekingalpha.com/news/3505691-aphria-22-percent-fq1-income-beats-consensus\" target=\"_blank\">reported</a> better-than-expected FQ1 earnings this morning.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505815\" data-linked=\"CannTrust up 22% on progress to address compliance issues\" data-tweet=\"$CTST - CannTrust up 22% on progress to address compliance issues https://seekingalpha.com/news/3505815-canntrust-up-22-on-progress-to-address-compliance-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3505815-canntrust-up-22-on-progress-to-address-compliance-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505816\" data-ts=\"1571153977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPL\" target=\"_blank\">GPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505816-great-pantherminus-13-after-cutting-tucano-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Panther -13% after cutting Tucano guidance</a></h4><ul><li>Great Panther Silver (<a href='https://seekingalpha.com/symbol/GPL' title='Great Panther Mining Limited'>GPL</a> <font color='red'>-13.2%</font>) <a href=\"https://seekingalpha.com/pr/17661886-great-panther-provides-update-tucano-gold-mine-guidance\" target=\"_blank\">cuts Q4 production guidance</a> for its Tucano mine in Brazil due to wall failures in one of the five pits scheduled for production in the quarter and into next year.</li><li>GPL says it has initiated a full geotechnical review of the Urucum Central South pit and all other pits at Tucano, which the company purchased in March.</li><li>To reflect the developments at Tucano, GPL lowers its Q4 production guidance for the mine to 39K-44K gold equiv. oz. and its full-year forecast to 110K-115K gold equiv. oz. from 125K-135K oz. previously.</li><li>GPL also trims its full-year guidance for Mexico production to 40K-45K gold equiv. oz. from 46.5K-50K oz.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505816\" data-linked=\"Great Panther -13% after cutting Tucano guidance\" data-tweet=\"$GPL - Great Panther -13% after cutting Tucano guidance https://seekingalpha.com/news/3505816-great-pantherminus-13-after-cutting-tucano-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505816-great-pantherminus-13-after-cutting-tucano-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505803\" data-ts=\"1571153079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505803-citron-bullish-on-bausch-health-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron bullish on Bausch Health, shares up 3%</a></h4><ul><li>Bausch Health Companies (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"green\">+3.3%</font>) perks up on almost 50% higher volume in reaction to a <a href=\"https://citronresearch.com/wp-content/uploads/2019/10/Bausch-Health-The-Textbook-Turnaround.pdf\" target=\"_blank\">bullish report</a> from original bear Citron Research.</li><li>Citron believes the stock could rise 84% to $40 as investors come around to its improved financial health, adding that the company has delivered two consecutive quarters of EBITDA growth, six consecutive quarters of organic revenue growth, launched products that could generate more than $1B in peak sales by the end of 2022 and cut debt by $8B since early 2016.</li><li>Citron was an <a href=\"https://seekingalpha.com/article/3589436-valeant-pharmaceutical-enron\" target=\"_blank\">early bear</a> on Valeant Pharmaceuticals under then-CEO Mike Pearson.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505803\" data-linked=\"Citron bullish on Bausch Health, shares up 3%\" data-tweet=\"$BHC - Citron bullish on Bausch Health, shares up 3% https://seekingalpha.com/news/3505803-citron-bullish-on-bausch-health-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3505803-citron-bullish-on-bausch-health-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505797\" data-ts=\"1571152010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXCM\" target=\"_blank\">DXCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505797-dexcom-down-6-on-abbott-tandem-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DexCom down 6% on Abbott/Tandem deal</a></h4><ul><li>DexCom (<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color=\"red\">-6%</font>) slips on modestly higher volume in apparent reaction to continuous glucose monitoring &#40;CGM&#41; competitor Abbott's announced <a href=\"https://seekingalpha.com/news/3505752-abbott-tandem-diabetes-explore-integrated-solutions-diabetes-tndm-shares-5-percent-premarket\" target=\"_blank\">partnership </a>with insulin pump seller Tandem Diabetes Care aimed at developing and commercializing integrated solutions with the former's <a href=\"https://www.freestylelibre.us/system-overview/freestyle-14-day.html\" target=\"_blank\">FreeStyle Libre</a> sensor-based CGM device.</li><li>Investors appear to perceive a potential competitive threat to DexCom's <a href=\"https://www.dexcom.com/g6-cgm-system\" target=\"_blank\">G6 CGM system</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505797\" data-linked=\"DexCom down 6% on Abbott/Tandem deal\" data-tweet=\"$DXCM - DexCom down 6% on Abbott/Tandem deal https://seekingalpha.com/news/3505797-dexcom-down-6-on-abbott-tandem-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3505797-dexcom-down-6-on-abbott-tandem-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505795\" data-ts=\"1571151724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505795-barra-joins-negotiations-two-sides-reportedly-move-closer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barra joins negotiations as two sides reportedly move closer</a></h4><ul><li>General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color=\"green\">+2.3%</font>) moves higher on reports that CEO Mary Barra has <a href=\"https://www.cnbc.com/2019/10/15/uaw-summons-local-union-leaders-to-detroit-as-gm-strike-continues.html\" target=\"_blank\">joined negotiations</a> with the United Auto Workers union, as the talks could be heading into \"the home stretch.\"</li><li>After publicly clashing last week, GM and the union are said to be <a href=\"https://www.wsj.com/articles/gm-uaw-negotiators-are-pressing-for-a-deal-to-end-30-day-strike-11571150340\" target=\"_blank\">closing in on a deal</a>, moving closer on key sticking points such as wages and the pay scale for new hires; the company may have given ground on a key demand by proposing to lower the eight-year period that a new hire must work to reach the top wage, now ~$30/hour.</li><li>In a possible sign of progress, UAW leadership yesterday called top union officials from local chapters around the country to Detroit for a Thursday update on the talks, a step the union traditionally has taken when a tentative deal has  been reached or, as was the case a month ago, to discuss and vote on  other actions such as a strike.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505795\" data-linked=\"Barra joins negotiations as two sides reportedly move closer\" data-tweet=\"$GM - Barra joins negotiations as two sides reportedly move closer https://seekingalpha.com/news/3505795-barra-joins-negotiations-two-sides-reportedly-move-closer?source=tweet\" data-url=\"https://seekingalpha.com/news/3505795-barra-joins-negotiations-two-sides-reportedly-move-closer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505791\" data-ts=\"1571151662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505791-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers: </b>Reata Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals, Inc.'>RETA</a>) <font color=\"green\">+61%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+25%</font>. Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"green\">+25%</font>. CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"green\">+21%</font>. Ra Medical Systems (NYSE:<a href='https://seekingalpha.com/symbol/RMED' title='Ra Medical Systems, Inc.'>RMED</a>) <font color=\"green\">+18%</font>.</li><li><b>Losers: </b>Milestone Scientific (NYSEMKT:<a href='https://seekingalpha.com/symbol/MLSS' title='Milestone Scientific Inc.'>MLSS</a>) <font color=\"red\">-7%</font>. electroCore (NASDAQ:<a href='https://seekingalpha.com/symbol/ECOR' title='electroCore, Inc.'>ECOR</a>) <font color=\"red\">-7%</font>. Auris Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding Ltd.'>EARS</a>) <font color=\"red\">-7%</font>. DexCom (NASDAQ:<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a>) <font color=\"red\">-6%</font>. AgeX Therapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/AGE' title='AgeX Therapeutics, Inc.'>AGE</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505791\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$RETA $APHA $ABEO - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3505791-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505791-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505792\" data-ts=\"1571151582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505792-zoom-videominus-1_8-after-lockup-expires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom Video -1.8% after lockup expires</a></h4><ul><li>Zoom Video (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) <font color=\"red\">dips 1.8%</font> as its IPO lockup period expires, unlocking roughly 230M shares for trading.</li><li>Zoom shares are <font color=\"green\">up 14%</font> since the April debut.</li><li>Related: Tech peer Pinterest also hit its <a href=\"https://seekingalpha.com/news/3505788-pinterest-minus-5-percent-lockup-expires\" target=\"_blank\">expiration date</a> today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505792\" data-linked=\"Zoom Video -1.8% after lockup expires\" data-tweet=\"$ZM - Zoom Video -1.8% after lockup expires https://seekingalpha.com/news/3505792-zoom-videominus-1_8-after-lockup-expires?source=tweet\" data-url=\"https://seekingalpha.com/news/3505792-zoom-videominus-1_8-after-lockup-expires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505788\" data-ts=\"1571151011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PINS\" target=\"_blank\">PINS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505788-pinterestminus-5-lockup-expires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pinterest -5% as lockup expires</a></h4><ul><li>Pinterest (NYSE:<a href='https://seekingalpha.com/symbol/PINS' title='Pinterest, Inc.'>PINS</a>) shares fall today as the IPO lockup expires, opening the door for early shareholders to sell shares.</li><li>Pinterest shares are currently <font color=\"red\">down 5%</font> to $24.66 but did drop as low as <font color=\"red\">6.4%</font> earlier, which was the lowest level since early June.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505788\" data-linked=\"Pinterest -5% as lockup expires\" data-tweet=\"$PINS - Pinterest -5% as lockup expires https://seekingalpha.com/news/3505788-pinterestminus-5-lockup-expires?source=tweet\" data-url=\"https://seekingalpha.com/news/3505788-pinterestminus-5-lockup-expires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505787\" data-ts=\"1571150677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505787-therapix-bio-up-21-on-encouraging-thxminus-210-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix Bio up 21% on encouraging THX-210 data</a></h4><ul><li>Thinly traded nano cap Therapix Biosciences (<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences Ltd.'>TRPX</a> <font color=\"green\">+20.6%</font>) is up on triple normal volume, albeit on turnover of only 331K shares, in response to positive <a href=\"https://seekingalpha.com/pr/17662346-therapix-biosciences-announces-positive-data-recent-pre-clinical-study-new-drug-candidate\" target=\"_blank\">preclinical data</a> on candidate THX-210, a pharmaceutical preparation containing cannabidiol &#40;CBD&#41; and a naturally occurring anti-inflammatory molecule called <a href=\"https://www.hindawi.com/journals/iji/2013/151028/\" target=\"_blank\">palmitoylethanolamide</a> &#40;PEA&#41;, that it intends to develop to treat epilepsy and inflammatory conditions.</li><li>Results from in vitro tests in hepatocyte models of fat accumulation showed that the effect of CBD was enhanced by the addition of PEA while PEA showed no effect alone, adding that THX-210 showed superior efficacy compared to CBD alone, the first time PEA has demonstrated a synergistic effect on CBD in such a model.</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505787\" data-linked=\"Therapix Bio up 21% on encouraging THX-210 data\" data-tweet=\"$TRPX - Therapix Bio up 21% on encouraging THX-210 data https://seekingalpha.com/news/3505787-therapix-bio-up-21-on-encouraging-thxminus-210-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3505787-therapix-bio-up-21-on-encouraging-thxminus-210-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505786\" data-ts=\"1571150637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSL\" target=\"_blank\">SSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505786-sasol-completes-lake-charles-review-results-set-for-oct-28-release\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sasol completes Lake Charles review, results set for Oct. 28 release</a></h4><ul><li>Sasol (<a href='https://seekingalpha.com/symbol/SSL' title='Sasol Limited'>SSL</a> <font color='green'>+4.3%</font>) starts higher after saying it <a href=\"https://seekingalpha.com/pr/17661754-sol-sasol-limited-timetable-announcement-outcome-independent-board-review-release-2019-annual\" target=\"_blank\">completed its review of cost overruns</a> at its Lake Charles, La., project and expects to release results on Oct. 28.</li><li>SSL has twice delayed its financial results for the year through the end of June due to the probe; the delay means the company is at risk of suspension from the Johannesburg Stock Exchange, although the threat should be removed once the results are released.</li><li>SSL, which warned of lower earnings in July as it wrote down the value of assets in North America and Africa, says it is considering the findings of the review to determine any appropriate steps to be announced \"in due course.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3505786\" data-linked=\"Sasol completes Lake Charles review, results set for Oct. 28 release\" data-tweet=\"$SSL - Sasol completes Lake Charles review, results set for Oct. 28 release https://seekingalpha.com/news/3505786-sasol-completes-lake-charles-review-results-set-for-oct-28-release?source=tweet\" data-url=\"https://seekingalpha.com/news/3505786-sasol-completes-lake-charles-review-results-set-for-oct-28-release\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505784\" data-ts=\"1571150485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRCY\" target=\"_blank\">MRCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505784-mercury-invests-15m-in-custom-microelectronics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercury invests $15M in custom microelectronics</a></h4><ul><li>Mercury Systems (<a href='https://seekingalpha.com/symbol/MRCY' title='Mercury Systems, Inc.'>MRCY</a> <font color='green'>+1.3%</font>) <a href=\"https://seekingalpha.com/pr/17662595-mercury-systems-announces-strategic-investment-trusted-microelectronics-technology-innovation\" target=\"_blank\">announces </a>the strategic investment to expand its trusted custom microelectronics business.</li><li>The $15M investment helps bring commercial silicon technology to the Department of Defense.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505784\" data-linked=\"Mercury invests $15M in custom microelectronics\" data-tweet=\"$MRCY - Mercury invests $15M in custom microelectronics https://seekingalpha.com/news/3505784-mercury-invests-15m-in-custom-microelectronics?source=tweet\" data-url=\"https://seekingalpha.com/news/3505784-mercury-invests-15m-in-custom-microelectronics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505780\" data-ts=\"1571149554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRSP\" target=\"_blank\">CRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505780-crispr-teams-up-ksq-therapeutics-in-cancer-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CRISPR teams up with KSQ Therapeutics in cancer; shares up 4%</a></h4><ul><li>Gene editor CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"green\">+3.8%</font>) and CRISPR/Cas9-focused biotech <a href=\"https://ksqtx.com/\" target=\"_blank\">KSQ Therapeutics</a> have inked reciprocal <a href=\"https://seekingalpha.com/pr/17661927-crispr-therapeutics-ksq-therapeutics-announce-license-agreement-advance-companies-respective\" target=\"_blank\">license agreements</a> aimed at advancing cell therapies for cancer.</li><li>Under the terms of the respective contracts, CRSP will receive non-exclusive access to KSQ's intellectual property &#40;IP&#41; for certain novel gene targets in its allogeneic oncology cell therapy programs while KSQ will gain non-exclusive access to CRSP's IP for editing novel gene targets identified by KSQ as part of its eTIL (engineered tumor infiltrating lymphocyte) cell programs.</li><li>Financial terms remain confidential.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505780\" data-linked=\"CRISPR teams up with KSQ Therapeutics in cancer; shares up 4%\" data-tweet=\"$CRSP - CRISPR teams up with KSQ Therapeutics in cancer; shares up 4% https://seekingalpha.com/news/3505780-crispr-teams-up-ksq-therapeutics-in-cancer-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3505780-crispr-teams-up-ksq-therapeutics-in-cancer-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505779\" data-ts=\"1571149537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505779-amc-theatres-launches-film-streaming-service\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMC Theatres launches film streaming service</a></h4><ul>   <li>AMC Theatres (<a href=\"http://seekingalpha.com/symbol/AMC\" target=\"_blank\">AMC</a> <font color=\"green\">+5.7%</font>) is starting a home invasion, launching a new <a href=\"https://seekingalpha.com/pr/17662281-amc-theatres-goes-home-launch-amc-theatres-demand\" target=\"_blank\">digital movie streaming service</a> to bring its brand out of theaters and onto televisions.</li>    <li>AMC Theatres on Demand launches today offering about 2,000 movies from top studios to its AMC Stubs subscription members, who can rent or buy on the platform.</li>    <li>The films will be available on the Web as well as mobile, connected devices and SmartTV applications.</li>    <li>In a cross-promotion partnership, later this fall AMC Stubs members will find movies from AMC Networks (<a href=\"http://seekingalpha.com/symbol/AMCX\" target=\"_blank\">AMCX</a> <font color=\"red\">-1.1%</font>) IFC Films and RLJE Films, and AMC Theatres will also promote AMC Networks' streaming services Acorn TV, Shudder, Sundance Now and UMC directly to moviegoers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505779\" data-linked=\"AMC Theatres launches film streaming service\" data-tweet=\"$AMC $AMCX - AMC Theatres launches film streaming service https://seekingalpha.com/news/3505779-amc-theatres-launches-film-streaming-service?source=tweet\" data-url=\"https://seekingalpha.com/news/3505779-amc-theatres-launches-film-streaming-service\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505774\" data-ts=\"1571148461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTV\" target=\"_blank\">PSTV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505774-plus-therapeutics-up-22-on-barda-reimbursement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plus Therapeutics up 22% on BARDA reimbursement</a></h4><ul><li>Nano cap Plus Therapeutics (<a href='https://seekingalpha.com/symbol/PSTV' title='Plus Therapeutics, Inc.'>PSTV</a> <font color=\"green\">+22.4%</font>) jumps on more than a 5x surge in volume in apparent response to a $4.6M reimbursement <a href=\"https://seekingalpha.com/pr/17662747-plus-therapeutics-receives-4_6mm-reimbursement-payment\" target=\"_blank\">payment </a>from BARDA under its September 2012 contract for work performed from 2012 through 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505774\" data-linked=\"Plus Therapeutics up 22% on BARDA reimbursement\" data-tweet=\"$PSTV - Plus Therapeutics up 22% on BARDA reimbursement https://seekingalpha.com/news/3505774-plus-therapeutics-up-22-on-barda-reimbursement?source=tweet\" data-url=\"https://seekingalpha.com/news/3505774-plus-therapeutics-up-22-on-barda-reimbursement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505767\" data-ts=\"1571147659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRC\" target=\"_blank\">FRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505767-first-republic-advance-5_2-after-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Republic advance 5.2% after Q3 beat</a></h4><ul><li>First Republic Bank (NYSE:<a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a>) <font color=\"green\">jumps 5.2%</font> after <a href=\"https://seekingalpha.com/pr/17662112-first-republic-reports-strong-third-quarter-2019-results\" target=\"_blank\">Q3 EPS</a> of $1.31 exceeds the average analyst estimate of $1.21; increases from $1.24 in Q2 and $1.19 in the year-ago quarter.</li><li>Q3 net interest income of $695.0M rises from $674.0M in Q2 and $634.5M in Q3 2018.</li><li>Q3 net interest margin of 2.80% vs. 2.85% in Q2.</li><li>Q3 loan originations of $11.1B marked FRC's best quarter ever.</li><li>Total deposits increased to $85.7B, up 15% Y/Y.</li><li>Q3 efficiency ratio of 63.8% vs. 64.5% in Q2.</li><li>Tangible book value per share of $48.84, rise 11% Y/Y.</li><li><a href=\"http://ir.firstrepublic.com/events-calendar\" target=\"_blank\">Conference call </a>at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3505713-first-republic-bank-eps-beats-0_10-misses-revenue\" target=\"_blank\">First Republic Bank EPS beats by $0.10, misses on revenue</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3505767\" data-linked=\"First Republic advance 5.2% after Q3 beat\" data-tweet=\"$FRC - First Republic advance 5.2% after Q3 beat https://seekingalpha.com/news/3505767-first-republic-advance-5_2-after-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3505767-first-republic-advance-5_2-after-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505761\" data-ts=\"1571147495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRNB\" target=\"_blank\">PRNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505761-principia-bio-up-3-on-positive-prn1008-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Principia Bio up 3% on positive PRN1008 data</a></h4><ul><li>Thinly traded Principia Biopharma (<a href='https://seekingalpha.com/symbol/PRNB' title='Principia Biopharma Inc.'>PRNB</a> <font color=\"green\">+2.8%</font>) is up out of the gate this morning in response to <a href=\"https://seekingalpha.com/pr/17662023-principia-announces-positive-preliminary-data-prn1008-immune-thrombocytopenia-ongoing-phase-1\" target=\"_blank\">positive preliminary data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03395210?lead=principia+biopharma&amp;phase=01&amp;rank=1\" target=\"_blank\">Phase 1/2 clinical trial</a> evaluating lead candidate PRN1008 for the treatment of <a href=\"https://emedicine.medscape.com/article/202158-overview\" target=\"_blank\">immune thrombocytopenia purpura</a> &#40;ITP&#41;, a condition characterized by easy bruising and a bleeding tendency due to low blood platelets.</li><li>26 participants have been enrolled to date. After a median duration of treatment of almost 13 weeks, 39% (n=10/26) achieved the primary efficacy endpoint of at least two consecutive platelet counts of at least 50K/µL at least five days apart and platelet count increases of at least 20K/µL from baseline without needing rescue medication. Preliminary results across all doses in patients who completed at least 12 weeks of treatment showed a response rate greater than 50% on both both primary endpoints (the other one is safety).</li><li>Updated data will be presented at ASH in early December.</li><li>PRN1008 is an optimized Bruton's tyrosine kinase &#40;BTK&#41; inhibitor that the company says enables rapid reversibility of effects on the immune system which makes it suitable for chronic therapy. It is also being developed to treat pemphigus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505761\" data-linked=\"Principia Bio up 3% on positive PRN1008 data\" data-tweet=\"$PRNB - Principia Bio up 3% on positive PRN1008 data https://seekingalpha.com/news/3505761-principia-bio-up-3-on-positive-prn1008-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3505761-principia-bio-up-3-on-positive-prn1008-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505763\" data-ts=\"1571146947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505763-grubminus-1_3-on-another-target-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GRUB -1.3% on another target cut</a></h4><ul><li>Barclays cuts its GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a>) target from $62 to $51, citing order growth deceleration due to an \"intense competitive environment\" plus \"lower frequency on new diner cohorts.\"</li><li>The firm says the current sentiment is \"very bearish\" and likely won't improve until \"FY20 estimates are reset.\" An in-line earnings report on October 23 could create \"a small relief rally.\"</li><li>Barclays maintains an Underweight rating. GRUB has an average <a href=\"https://seekingalpha.com/symbol/GRUB/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a> of Outperform.</li><li>GRUB shares are <font color=\"red\">down 1.3%</font> to $53.70.</li><li>Related: Morgan Stanley also <a href=\"https://seekingalpha.com/news/3505729-grubhub-gets-price-target-trim\" target=\"_blank\">trimmed</a> its GRUB target this morning.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505763\" data-linked=\"GRUB -1.3% on another target cut\" data-tweet=\"$GRUB - GRUB -1.3% on another target cut https://seekingalpha.com/news/3505763-grubminus-1_3-on-another-target-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3505763-grubminus-1_3-on-another-target-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505758\" data-ts=\"1571146121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505758-ericsson-partners-xtreme-on-rural-u-s-internet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson partners with Xtreme on rural U.S. Internet</a></h4><ul>   <li>Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='Telefonaktiebolaget LM Ericsson &#40;publ&#41;'>ERIC</a>) is <a href=\"https://seekingalpha.com/pr/17662534-ericsson-partners-xtreme-enterprises-support-rural-wisps-america\" target=\"_blank\">partnering with Xtreme Enterprises</a> in support of rural wireless Internet service providers in America.</li>    <li>The company will include its Ericsson Radio System in the solution and service portfolio for Pennsylvania-based Xtreme, which has worked as a WISP and cellular carrier for decades.</li>    <li>Xtreme will offer Ericsson's high-performance Micro Radio 2208 for Citizens Broadband Radio Service, which uses the highest allowable power output for outdoor CBRS deployments.</li>    <li>Ericsson is <font color=\"green\">up 1.6%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505758\" data-linked=\"Ericsson partners with Xtreme on rural U.S. Internet\" data-tweet=\"$ERIC - Ericsson partners with Xtreme on rural U.S. Internet https://seekingalpha.com/news/3505758-ericsson-partners-xtreme-on-rural-u-s-internet?source=tweet\" data-url=\"https://seekingalpha.com/news/3505758-ericsson-partners-xtreme-on-rural-u-s-internet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505756\" data-ts=\"1571145859\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNX\" target=\"_blank\">KNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505756-knight-swift-cuts-q3-q4-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knight-Swift cuts Q3, Q4 earnings guidance</a></h4><ul><li>Knight-Swift Transportation (NYSE:<a href='https://seekingalpha.com/symbol/KNX' title='Knight-Swift Transportation Holdings Inc.'>KNX</a>) <font color=\"red\">-2.8%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17662487-knight-swift-transportation-holdings-inc-announces-updated-earnings-guidance\" target=\"_blank\">lowering EPS guidance</a> for both Q3 and Q4, citing \"increased competition within the intermodal market, leading to  unexpected reductions in volume and revenue per load, and greater than  expected pressure on freight rates, primarily due to an oversupply of  truckload capacity.\"</li><li>KNX now expects Q3 adjusted EPS of $0.47-$0.48 vs. its previous guidance of $0.54-$0.57 and analyst consensus of $0.53, and Q4 adjusted EPS of $0.62-$0.65 vs. its prior outlook of $0.73-$0.77 and analyst consensus of $0.71; the company also forecasts Q1 2020 EPS of $0.42-$0.46.</li><li>KNX believes the rationalization of capacity has accelerated and should lead to a more favorable freight environment in H2 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505756\" data-linked=\"Knight-Swift cuts Q3, Q4 earnings guidance\" data-tweet=\"$KNX - Knight-Swift cuts Q3, Q4 earnings guidance https://seekingalpha.com/news/3505756-knight-swift-cuts-q3-q4-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3505756-knight-swift-cuts-q3-q4-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505754\" data-ts=\"1571145713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505754-apha-nio-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APHA, NIO among premarket gainers</a></h4><ul><li>Westwater Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/WWR' title='Westwater Resources, Inc.'>WWR</a>) <font color=\"green\">+130%</font> on <a href=\"https://seekingalpha.com/pr/17662117-westwater-resources-receives-first-shipment-graphite-concentrate\" target=\"_blank\">receiving</a> first shipment of graphite concentrate.</li><li>Reata Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals, Inc.'>RETA</a>) <font color=\"green\">+47%</font> as <a href=\"https://seekingalpha.com/news/3505622-reatas-omaveloxolone-successful-mid-stage-fa-study\" target=\"_blank\">omaveloxolone</a> successful in mid-stage FA study.</li><li>NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"green\">+18%</font>.</li><li>AgroFresh Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/AGFS' title='AgroFresh Solutions, Inc.'>AGFS</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3505640-agrofresh-wins-31m-damage-award-decco-case\" target=\"_blank\">$31M damage</a> award in Decco case.</li><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"green\">+17%</font> on <a href=\"https://seekingalpha.com/news/3505683-aphria-eps-beats-c-0_10-misses-revenue\" target=\"_blank\">Q1 result</a>.</li><li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) <font color=\"green\">+17%</font> on preliminary <a href=\"https://seekingalpha.com/news/3505743-viewray-plus-13-percent-premarket-preliminary-q3-results\" target=\"_blank\">Q3 results</a>.</li><li>New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"green\">+14%</font>.</li><li>Immutep (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMP' title='Immutep Limited'>IMMP</a>) <font color=\"green\">+11%</font>.</li><li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3505643-glu-mobile-plus-8_2-percent-s-and-p-index-move\" target=\"_blank\">S&amp;P index move</a>.</li><li>CEL-SCI (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='CEL-SCI Corporation'>CVM</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3505750-cel-sci-4-percent-premarket-continuation-phase-3-multikine-study\" target=\"_blank\">continuation</a> of Phase 3 Multikine study.</li><li>Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3505712-neovasc-nabs-new-patent-u-s-shares-14-percent-premarket\" target=\"_blank\">new patent</a> in U.S.</li><li>NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505754\" data-linked=\"APHA, NIO among premarket gainers\" data-tweet=\"$WWR $RETA $BIMI - APHA, NIO among premarket gainers https://seekingalpha.com/news/3505754-apha-nio-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505754-apha-nio-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505753\" data-ts=\"1571145446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505753-mallinckrodt-operations-chief-bids-adieu\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mallinckrodt operations chief bids adieu</a></h4><ul><li>Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>) EVP and Chief Operations and Digital Innovation Officer Dr. Frank Scholz has <a href=\"https://www.sec.gov/ix?doc=/Archives/edgar/data/1567892/000156789219000049/mnk8-k101419.htm\" target=\"_blank\">resigned </a>effective October 21.</li><li>Shares up <font color=\"green\">3%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505753\" data-linked=\"Mallinckrodt operations chief bids adieu\" data-tweet=\"$MNK - Mallinckrodt operations chief bids adieu https://seekingalpha.com/news/3505753-mallinckrodt-operations-chief-bids-adieu?source=tweet\" data-url=\"https://seekingalpha.com/news/3505753-mallinckrodt-operations-chief-bids-adieu\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505752\" data-ts=\"1571145361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABT\" target=\"_blank\">ABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505752-abbott-and-tandem-diabetes-to-explore-integrated-solutions-for-diabetes-tndm-shares-up-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abbott and Tandem Diabetes to explore integrated solutions for diabetes; TNDM shares up 5% premarket</a></h4><ul><li>Abbott (NYSE:<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a>) and Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) <a href=\"https://seekingalpha.com/pr/17662213-abbott-tandem-diabetes-care-exploring-new-integrated-solutions-improve-diabetes-management\" target=\"_blank\">intends</a> to develop and commercialize integrated diabetes solutions combining Abbott's FreeStyle Libre, a sensor-based glucose monitoring system with Tandem's insulin delivery systems to provide more options for people to manage their diabetes.</li><li>TNDM shares are up <font color=\"green\">5%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505752\" data-linked=\"Abbott and Tandem Diabetes to explore integrated solutions for diabetes; TNDM shares up 5% premarket\" data-tweet=\"$ABT $TNDM - Abbott and Tandem Diabetes to explore integrated solutions for diabetes; TNDM shares up 5% premarket https://seekingalpha.com/news/3505752-abbott-and-tandem-diabetes-to-explore-integrated-solutions-for-diabetes-tndm-shares-up-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3505752-abbott-and-tandem-diabetes-to-explore-integrated-solutions-for-diabetes-tndm-shares-up-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505750\" data-ts=\"1571145137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505750-cel-sci-up-4-premarket-on-continuation-of-phase-3-multikine-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cel-Sci up 4% premarket on continuation of Phase 3 Multikine study</a></h4><ul><li>CEL-SCI (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='CEL-SCI Corporation'>CVM</a>) is up <font color=\"green\">4%</font> premarket on modestly higher volume in reaction to its <a href=\"https://seekingalpha.com/pr/17662314-cel-sci-reports-recent-data-review-independent-data-monitoring-committee-pivotal-phase-3-head\" target=\"_blank\">announcement </a>that its <a href=\"https://clinicaltrials.gov/ct2/show/NCT01265849?lead=cel-sci&amp;phase=2&amp;rank=1\" target=\"_blank\">Phase 3 clinical trial</a> evaluating MultiKine (leukocyte interleukin, injection), combined with chemo agent cyclophosphamide, NSAID indomethacin and zinc in a multivitamin combo prior to radiotherapy, in head and neck cancer patients will continue unchanged until the requisite number of events (deaths) have occurred for the primary endpoint of overall survival.</li><li>Secondary endpoints include progression-free survival and quality of life measures.</li><li>The estimated completion date is December per ClinicalTrials.gov.</li><li>MultiKine is mass-produced biologic containing 14 natural human cytokines designed to boost the immune response to cancer. The company is developing the immunotherapy as a neoadjuvant to be administered right after diagnosis and before surgery.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505750\" data-linked=\"Cel-Sci up 4% premarket on continuation of Phase 3 Multikine study\" data-tweet=\"$CVM - Cel-Sci up 4% premarket on continuation of Phase 3 Multikine study https://seekingalpha.com/news/3505750-cel-sci-up-4-premarket-on-continuation-of-phase-3-multikine-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3505750-cel-sci-up-4-premarket-on-continuation-of-phase-3-multikine-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505748\" data-ts=\"1571144863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505748-pags-ses-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PAGS, SES among premarket losers</a></h4><ul><li>Synthesis Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/SES' title='Synthesis Energy Systems, Inc.'>SES</a>) <font color=\"red\">-15%</font>.</li><li>Yuma Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a>) <font color=\"red\">-14%</font>.</li><li>Taronis Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TRNX' title='Taronis Technologies, Inc.'>TRNX</a>) <font color=\"red\">-9%</font>.</li><li>PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505748\" data-linked=\"PAGS, SES among premarket losers\" data-tweet=\"$SES $YUMA $TRNX - PAGS, SES among premarket losers https://seekingalpha.com/news/3505748-pags-ses-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3505748-pags-ses-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505747\" data-ts=\"1571144855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505747-rokuplus-3_2-apple-tv-app-apple-tv-plus-joining-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku +3.2% as Apple TV app, Apple TV Plus joining platform</a></h4><ul>   <li>Roku (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a>) is <font color=\"green\">up 3.2%</font> premarket on the news that Apple TV app and Apple TV Plus (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) are <a href=\"https://seekingalpha.com/pr/17662501-apple-tv-app-apple-tv-coming-roku-platform\" target=\"_blank\">coming to the company's TV platform</a>.</li>    <li>Apple's TV app is available starting today. On Nov. 1, Apple's TV Plus will be available through the app in supported regions.</li>    <li>Along with the U.S., Apple's TV app is available to Roku users in Argentina, Canada, Chile, Colombia, Costa Rica, El Salvador, France, Guatemala, Honduras, Mexico, Nicaragua, Panama, Peru, Republic of Ireland and the United Kingdom.</li>    <li>Apple is <font color=\"green\">up 0.2%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3505747\" data-linked=\"Roku +3.2% as Apple TV app, Apple TV Plus joining platform\" data-tweet=\"$ROKU $AAPL - Roku +3.2% as Apple TV app, Apple TV Plus joining platform https://seekingalpha.com/news/3505747-rokuplus-3_2-apple-tv-app-apple-tv-plus-joining-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3505747-rokuplus-3_2-apple-tv-app-apple-tv-plus-joining-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505743\" data-ts=\"1571144630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRAY\" target=\"_blank\">VRAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505743-viewrayplus-13-premarket-on-preliminary-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViewRay +13% premarket on preliminary Q3 results</a></h4><ul> <li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) is up <font color=\"green\">13%</font> premarket on <a href=\"https://seekingalpha.com/pr/17662343-viewray-announces-preliminary-third-quarter-2019-results-details-upcoming-conference-call\" target=\"_blank\">announcing</a> preliminary Q3 2019 results:</li><li>Q3 total revenue of $20.9M, compared to $17.7M in Q3 2018.</li><li>Received 8 new orders for MRIdian systems, totaling ~$35M.</li><li>Total backlog grew to ~$231M as of September 30, 2019.</li><li>Cash and equivalents were ~$92M as of September 30.</li><li>The Company reaffirmed its FY 2019 guidance of revenue in the range of $80M - 95M, and cash use in the range of $80M - 90M.</li>    <li>The company will hold a conference call on November 12, 2019 at 4:30 p.m. ET / 1:30 p.m. PT to discuss results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505743\" data-linked=\"ViewRay +13% premarket on preliminary Q3 results\" data-tweet=\"$VRAY - ViewRay +13% premarket on preliminary Q3 results https://seekingalpha.com/news/3505743-viewrayplus-13-premarket-on-preliminary-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3505743-viewrayplus-13-premarket-on-preliminary-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505739\" data-ts=\"1571144237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLMN\" target=\"_blank\">BLMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505739-bloominminus-1_9-deutsche-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomin&#39; -1.9% as Deutsche hits sidelines</a></h4><ul><li>Deutsche Bank downgrades Bloomin' Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/BLMN' title='Bloomin&#39; Brands, Inc.'>BLMN</a>) from Buy to Hold and cuts its Q3 comps estimate from a 1.1% increase to a 0.6% increase.</li><li>The firm says it is also becoming more conservative on next year's comparable sales estimates.</li><li>BLMN shares are <font color=\"red\">down 1.9%</font> pre-market to $17.80. The company has an Outperform average<a href=\"https://seekingalpha.com/symbol/BLMN/ratings/sell-side-ratings\" target=\"_blank\"> Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505739\" data-linked=\"Bloomin&#39; -1.9% as Deutsche hits sidelines\" data-tweet=\"$BLMN - Bloomin&#39; -1.9% as Deutsche hits sidelines https://seekingalpha.com/news/3505739-bloominminus-1_9-deutsche-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3505739-bloominminus-1_9-deutsche-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505735\" data-ts=\"1571143722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505735-charles-schwab-eps-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles Schwab EPS beats by $0.10, beats on revenue</a></h4><ul><li>Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>): Q3 Non-GAAP EPS of $0.74 <font color=\"green\">beats by $0.10</font>; GAAP EPS of $0.70 <font color=\"green\">beats by $0.06</font>.</li><li>Revenue of $2.71B (+5.0% Y/Y) <font color=\"green\">beats by $60M</font>.</li><li>Shares <font color=\"green\">+2.7%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17662451-schwab-reports-record-earnings-per-share-70-8-percent\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3505735\" data-linked=\"Charles Schwab EPS beats by $0.10, beats on revenue\" data-tweet=\"$SCHW - Charles Schwab EPS beats by $0.10, beats on revenue https://seekingalpha.com/news/3505735-charles-schwab-eps-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3505735-charles-schwab-eps-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505730\" data-ts=\"1571143006\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLMD\" target=\"_blank\">RLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505730-relmada-up-84-premarket-on-positive-relminus-1017-data-in-treatment-resistant-depression\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relmada up 84% premarket on positive REL-1017 data in treatment-resistant depression</a></h4><ul><li>Relmada Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RLMD' title='Relmada Therapeutics, Inc.'>RLMD</a>) <a href=\"https://seekingalpha.com/pr/17662152-relmada-therapeutics-announces-top-line-results-relminus-1017-phase-2-study-individuals\" target=\"_blank\">announces</a> positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03051256?lead=relmada+therapeutics&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating REL-1017 (dextromethadone) in adult patients with major depressive disorder &#40;MDD&#41; who have failed to respond adequately to as many as three prior courses of treatment with antidepressant medication. The study assessed two daily doses (25 mg and 50 mg) as adjunctive treatment.</li><li>Participants in both dose arms experienced statistically significant improvements in their depression compared to placebo across all efficacy measures (four scales) with a favorable safety profile.</li><li>The company plans to meet with the FDA to clarify a registration path.</li><li>Fast Track-tagged dextromethadone is an orally administered NMDA receptor antagonist. The company says it does not have the unwanted psychomimetic side effects of ketamine. </li><li>Shares up <font color=\"green\">84%</font> premarket on increased volume, albeit on turnover of only 14K shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505730\" data-linked=\"Relmada up 84% premarket on positive REL-1017 data in treatment-resistant depression\" data-tweet=\"$RLMD - Relmada up 84% premarket on positive REL-1017 data in treatment-resistant depression https://seekingalpha.com/news/3505730-relmada-up-84-premarket-on-positive-relminus-1017-data-in-treatment-resistant-depression?source=tweet\" data-url=\"https://seekingalpha.com/news/3505730-relmada-up-84-premarket-on-positive-relminus-1017-data-in-treatment-resistant-depression\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505726\" data-ts=\"1571142736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RKDA\" target=\"_blank\">RKDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505726-arcadia-bioplus-4-premarket-on-jv-update-archipelago-ventures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcadia Bio +4% premarket on JV update with Archipelago Ventures</a></h4><ul><li>Arcadia Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences, Inc.'>RKDA</a>) is up 4% premarket after an <a href=\"https://seekingalpha.com/pr/17661797-arcadia-biosciences-advances-hemp-operations-archipelago-ventures\" target=\"_blank\">update</a> on its Joint Venture &#40;JV&#41; with Legacy Ventures Hawaii, Archipelago Ventures. The JV has:</li><li>Expanded its cultivation footprint on Hawaii by 3x, from 10 to 30 acres, through partnerships with two new license holders.</li><li>Introduced a new autoflowering hemp varietal to Hawaii's pilot program.</li><li>Begun the build of large-scale mobile extraction and processing equipment to produce tetrahydrocannabinol &#40;THC&#41;-free, sun-grown hemp isolate or distillate.</li>                    </ul><div class=\"tiny-share-widget\" data-id=\"3505726\" data-linked=\"Arcadia Bio +4% premarket on JV update with Archipelago Ventures\" data-tweet=\"$RKDA - Arcadia Bio +4% premarket on JV update with Archipelago Ventures https://seekingalpha.com/news/3505726-arcadia-bioplus-4-premarket-on-jv-update-archipelago-ventures?source=tweet\" data-url=\"https://seekingalpha.com/news/3505726-arcadia-bioplus-4-premarket-on-jv-update-archipelago-ventures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505720\" data-ts=\"1571141799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505720-lowes-upgraded-piper-jaffray-fundamentals-top-modest-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lowe&#39;s upgraded at Piper Jaffray as fundamentals top &#39;modest&#39; expectations</a></h4><ul><li>Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>) <font color=\"green\">+1.9%</font> pre-market after Piper Jaffray <a href=\"https://thefly.com/thestreet/realmoney/index.php/LOWid2975269/LOW-Lowes-upgraded-to-Overweight-from-Neutral-at-Piper-Jaffray\" target=\"_blank\">upgrades shares to Overweight</a> from Neutral with a $130 price target, raised from $113, as analyst Peter Keith says the company's fundamentals look poised for acceleration in H2 2019 and 2020, \"yet expectations seem modest.\"</li><li>The firm's industry analysis indicates the housing and home remodel backdrop will strengthen into H1 2020, and Keith sees a path for accelerating comp-store growth and gross margin for the company amid such a backdrop.</li><li>LOW's risk/reward looks favorable, Keith says, with 40%-plus upside potential vs. 10% downside risk over the next 12 months.</li><li>LOW's average <a href=\"https://seekingalpha.com/symbol/LOW/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, while its <a href=\"https://seekingalpha.com/symbol/LOW/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505720\" data-linked=\"Lowe&#39;s upgraded at Piper Jaffray as fundamentals top &#39;modest&#39; expectations\" data-tweet=\"$LOW - Lowe&#39;s upgraded at Piper Jaffray as fundamentals top &#39;modest&#39; expectations https://seekingalpha.com/news/3505720-lowes-upgraded-piper-jaffray-fundamentals-top-modest-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3505720-lowes-upgraded-piper-jaffray-fundamentals-top-modest-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505707\" data-ts=\"1571141753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505707-goldman-neutral-on-amarin-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman neutral on Amarin in premarket analyst action</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation plc'>AMRN</a>) resumed with Neutral rating and $17 (10% upside) price target at Goldman Sachs. Shares down a fraction premarket.</li><li>Hoth Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HOTH' title='Hoth Therapeutics, Inc.'>HOTH</a>) initiated with Speculative Buy rating at Benchmark.</li><li>Knight Therapeutics ((GUD CN)) initiated with Buy rating and C$8.50 (12% upside) price target at Canaccord Genuity.</li><li>Medexus Pharmaceuticals ((MDP CN)) initiated with Buy rating and C$6.50 (56% upside) price target at Canaccord.</li><li>EHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a>) initiated with Outperform rating and $90 (69% upside) price target at Raymond James.</li><li>Zealand Pharma A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/ZEAL' title='Zealand Pharma A/S'>ZEAL</a>) upgraded to Buy with a $41 (77% upside) price target at Goldman.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505707\" data-linked=\"Goldman neutral on Amarin in premarket analyst action\" data-tweet=\"$AMRN $AMGN $HOTH - Goldman neutral on Amarin in premarket analyst action https://seekingalpha.com/news/3505707-goldman-neutral-on-amarin-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3505707-goldman-neutral-on-amarin-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505715\" data-ts=\"1571141279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505715-bed-bath-beyond-upped-keybanc-store-sales-trends-improve\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond upped at KeyBanc as same-store sales trends improve</a></h4><ul><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"green\">+3.3%</font> pre-market after KeyBanc <a href=\"https://thefly.com/thestreet/realmoney/index.php/BBBYid2975304/BBBY-KeyBanc-upgrades-Bed-Bath--Beyond-on-sizable-upside-opportunity\" target=\"_blank\">upgrades shares to Overweight</a> from  Sector Weight with an $18 price target, which would imply a nearly one-third upside.</li><li>KeyBanc analyst Bradley Thomas says the firm's proprietary data suggests BBBY's same-store sales trends have been improving, and he believes new CEO Mark Tritton and his merchandising background should be a strong fit for the company's needs.</li><li>Also, asset sales \"could happen sooner rather than later\" and could be material, while the stock's valuation points to a \"sizable upside opportunity\" with relatively bearish sentiment already baked in, Thomas says.</li><li>BBBY's average <a href=\"https://seekingalpha.com/symbol/BBBY/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Hold, while its <a href=\"https://seekingalpha.com/symbol/BBBY/ratings/sell-side-ratings\" target=\"_blank\">Seeking Alpha Authors Rating</a> is Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505715\" data-linked=\"Bed Bath &amp; Beyond upped at KeyBanc as same-store sales trends improve\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond upped at KeyBanc as same-store sales trends improve https://seekingalpha.com/news/3505715-bed-bath-beyond-upped-keybanc-store-sales-trends-improve?source=tweet\" data-url=\"https://seekingalpha.com/news/3505715-bed-bath-beyond-upped-keybanc-store-sales-trends-improve\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505712\" data-ts=\"1571141141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505712-neovasc-nabs-new-patent-in-u-s-shares-up-14-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc nabs new patent in U.S.; shares up 14% premarket</a></h4><ul> <li>The USPTO has <a href=\"https://seekingalpha.com/pr/17662029-neovasc-announces-notice-us-patent-granted-tiara-tm-transcatheter-device-treatment-severe\" target=\"_blank\">issued</a> Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>), Patent No. 10,433,952, titled: \u201cPROSTHETIC VALVE FOR AVOIDING OBSTRUCTION OF OUTFLOW\u201d.</li>    <li>The granted claims are directed to a prosthetic valve that helps reduce LVOT obstruction and improve unobstructed blood flow through the Tiara and the native ventricle.</li>    <li>Shares are up <font color=\"green\">14%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3505712\" data-linked=\"Neovasc nabs new patent in U.S.; shares up 14% premarket\" data-tweet=\"$NVCN - Neovasc nabs new patent in U.S.; shares up 14% premarket https://seekingalpha.com/news/3505712-neovasc-nabs-new-patent-in-u-s-shares-up-14-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3505712-neovasc-nabs-new-patent-in-u-s-shares-up-14-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505704\" data-ts=\"1571140728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505704-canopy-growth-completes-acquisition-of-beckley-canopy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth completes acquisition of Beckley Canopy</a></h4><ul> <li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <a href=\"https://seekingalpha.com/pr/17661923-canopy-growth-completes-previously-announced-acquisition-beckley-canopy-therapeutics\" target=\"_blank\">completes</a> acquisition of all outstanding shares in Beckley Canopy Therapeutics, including the joint commercial venture Spectrum Biomedical UK.</li>                  <li>As a part of the acquisition, CGC's European management structure will evolve. Paul Steckler and Steven Wooding will assume the roles of Co-Managing Directors in charge of all European operations.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3505704\" data-linked=\"Canopy Growth completes acquisition of Beckley Canopy\" data-tweet=\"$CGC - Canopy Growth completes acquisition of Beckley Canopy https://seekingalpha.com/news/3505704-canopy-growth-completes-acquisition-of-beckley-canopy?source=tweet\" data-url=\"https://seekingalpha.com/news/3505704-canopy-growth-completes-acquisition-of-beckley-canopy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3505703\" data-ts=\"1571140608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3505703-can-fite-completes-enrollment-in-mid-stage-nafld-study-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite completes enrollment in mid-stage NAFLD study; shares up 6% premarket</a></h4><ul><li>Thinly traded nano cap Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) is up <font color=\"green\">6% </font>premarket on light volume in reaction to its <a href=\"https://seekingalpha.com/pr/17661885-can-fite-completes-patient-enrollment-phase-ii-nash-study-namodenoson\" target=\"_blank\">announcement </a>that it has completed the enrollment of 60 subjects in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02927314?lead=can-fite&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating Namodenoson (CF102) in patients with nonalcoholic fatty liver disease &#40;NAFLD&#41; with or without NASH.</li><li>The primary endpoint is the mean change from baseline in a liver enzyme called ALT (elevated ALT is a biomarker for liver stress/damage) versus placebo.</li><li>Topline results should be available in Q1 2020. If successful, a Phase 3 study will follow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3505703\" data-linked=\"Can-Fite completes enrollment in mid-stage NAFLD study; shares up 6% premarket\" data-tweet=\"$CANF - Can-Fite completes enrollment in mid-stage NAFLD study; shares up 6% premarket https://seekingalpha.com/news/3505703-can-fite-completes-enrollment-in-mid-stage-nafld-study-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3505703-can-fite-completes-enrollment-in-mid-stage-nafld-study-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}